<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1038/s41598-023-27777-z</query><apiKey>87ba7cb21f89ce78154df796840621f4</apiKey><result><total>1</total><start>1</start><pageLength>2</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="publisher-id">41598</journal-id><journal-id journal-id-type="doi">10.1038/41598.2045-2322</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title><abbrev-journal-title abbrev-type="publisher">Sci Rep</abbrev-journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s41598-023-27777-z</article-id><article-id pub-id-type="manuscript">27777</article-id><article-id pub-id-type="doi">10.1038/s41598-023-27777-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/639/638</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/639/638/403</subject></subj-group><subj-group subj-group-type="SubjectPath"><subject>/639/638/549</subject></subj-group><subj-group subj-group-type="NatureArticleTypeID"><subject>article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Synthesis, antimicrobial activity and molecular docking studies of spiroquinoline-indoline-dione and spiropyrazolo-indoline-dione derivatives</article-title></title-group><contrib-group><contrib contrib-type="author" id="Au1"><name><surname>Gul</surname><given-names>Melek</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Turk Celikoglu</surname><given-names>Emine</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Idil</surname><given-names>Onder</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Tas</surname><given-names>Gamze</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes" id="Au5"><name><surname>Pelit</surname><given-names>Emel</given-names></name><address><email>epelit@klu.edu.tr</email><email>emelpelit@yahoo.com</email></address><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="corresp" rid="IDs4159802327777z_cor5">e</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411355.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 6723</institution-id><institution content-type="org-division">Department of Chemistry, Faculty of Art and Sciences</institution><institution content-type="org-name">Amasya University</institution></institution-wrap><addr-line content-type="postcode">05100</addr-line><addr-line content-type="city">Amasya</addr-line><country country="TR">Turkey</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411355.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 6723</institution-id><institution content-type="org-division">Department of Biology, Faculty of Art and Sciences</institution><institution content-type="org-name">Amasya University</institution></institution-wrap><addr-line content-type="postcode">05100</addr-line><addr-line content-type="city">Amasya</addr-line><country country="TR">Turkey</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411355.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 6723</institution-id><institution content-type="org-division">Department of Pre-School Education, Faculty of Education</institution><institution content-type="org-name">Amasya University</institution></institution-wrap><addr-line content-type="postcode">05100</addr-line><addr-line content-type="city">Amasya</addr-line><country country="TR">Turkey</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.448786.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0399 5728</institution-id><institution content-type="org-division">Department of Chemistry, Faculty of Art and Sciences</institution><institution content-type="org-name">Kirklareli University</institution></institution-wrap><addr-line content-type="postcode">39100</addr-line><addr-line content-type="city">Kirklareli</addr-line><country country="TR">Turkey</country></aff></contrib-group><author-notes><corresp id="IDs4159802327777z_cor5"><label>e</label><email>epelit@klu.edu.tr</email><email>emelpelit@yahoo.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>1</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2023</year></pub-date><volume>13</volume><issue seq="1676">1</issue><elocation-id>1676</elocation-id><history><date date-type="registration"><day>9</day><month>1</month><year>2023</year></date><date date-type="received"><day>16</day><month>10</month><year>2022</year></date><date date-type="accepted"><day>9</day><month>1</month><year>2023</year></date><date date-type="online"><day>30</day><month>1</month><year>2023</year></date></history><permissions><copyright-statement content-type="compact">© The Author(s) 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract xml:lang="en" id="Abs1"><title>Abstract</title><p id="Par1">Spiro[benzo[h]quinoline-7,3′-indoline]diones and spiro[indoline-3,4′-pyrazolo[3,4-b]quinoline]diones were efficiently synthesized via one-pot multi-component reactions under ultrasound-promoted conditions. Spiro[benzo[h]quinoline-7,3′-indoline]dione derivatives were successfully developed by the reaction of isatins, naphthalene-1-amine and 1,3-dicarbonyl compounds. The spiro[indoline-3,4′-pyrazolo[3,4-b]quinoline]dione derivatives were prepared by the reaction of isatins, 5-amino-1-methyl-3-pheylpyrazole, and 1,3-dicarbonyl compounds by using ( ±)-camphor-10-sulfonic acid as a catalyst in H<sub>2</sub>O/EtOH (3:1 v/v) solvent mixture. The antibacterial activity of the synthesized compounds was evaluated against, <italic>Enterococcus faecalis</italic>, <italic>Staphylococcus aureus</italic> and <italic>Candida albicans</italic>. Compounds 4b, 4h, and 6h showed the strongest antimicrobial activity toward both bacteria. The MIC values of these compounds ranged from 375–3000 µg/mL. The effect of these compounds (4b, 4h, 6h) as a function of applied dose and time was investigated by a kinetic study, and the interaction with these antimicrobial results was simulated by a molecular docking study. We also used the docking approach with Covid-19 since secondary bacterial infections. Docking showed that indoline-quinoline hybrid compounds 4b and 4h exerted the strongest docking binding value against the active sites of 6LU7. In addition, the synthesized compounds had a moderate to good free radical scavenging activity.
</p></abstract><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>Nature Portfolio</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>1676</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2023</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2023</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2023</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>9</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>NonStandardArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/41598_2023_Article_27777.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Science, Humanities and Social Sciences, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Science, Humanities and Social Sciences, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Science, multidisciplinary</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Science (multidisciplinary)</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Multicomponent reactions are valuable organic reactions in which three or more reactants react in a one-pot process to produce a final product<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. These reactions have tremendous efficiency, especially for the synthesis of heterocyclic compounds that exhibit a wide range of biological activities<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Multicomponent reactions comply with the principles of green chemistry in terms of a high degree of atom economy, easier progress of reactions, low energy consumption, short reaction times, and lack of waste products<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p><p id="Par3">Quinoline and indole are importat moieties of a large number of natural products and biologically active compounds<sup><xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR7">7</xref></sup>. Quinoline derivatives were found to have anticancer<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, anti-HIV<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, antibacterial<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>, antimalarial<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, anti-inflammatory<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> activities. Indole derivatives also exhibit antimicrobial<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>, antibacterial<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, anti-inflammatory<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, antiviral<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, antidiabetic<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, antitumor<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, and anticancer<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> activities. The spiro-fuced oxindole moiety is also a significant core structure of many pharmacological agents and natural products<sup><xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR23">23</xref></sup> and additionally has also been shown to be a potential fluorescent materials<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. On the other hand heterocylic compounds containing a pyrazole moiety exhibit anti-HIV<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, anticancer<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>, antifungal<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, and antimicrobial<sup><xref ref-type="bibr" rid="CR30">30</xref>–<xref ref-type="bibr" rid="CR32">32</xref></sup> activities. Due to the broad biological activities of these spiro-fuced oxindole and pyrazole derivatives many synthetic methods for their preparation have been described<sup><xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR43">43</xref></sup>. In addition, various catalysts such as HOAc<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, PTSA<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>, CAN<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, L-Proline<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, [NMP]H<sub>2</sub>PO<sub>4</sub><sup><xref ref-type="bibr" rid="CR48">48</xref></sup>, ChCl/Lac<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, Papain<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, and Cu(OTf)<sub>2</sub><sup><xref ref-type="bibr" rid="CR51">51</xref></sup> have been used to promote this reaction.</p><p id="Par4">The improvement of diverse synthetic processes that provide better environmental performance in synthetic organic chemistry is an objective<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Ultrasound irradiation promotes many organic reactions, owing to cavitational collapse. Various organic reactions can be effectively accomplished in higher yields, with shorter reaction times, and under milder reaction conditions using ultrasonic irradiation<sup><xref ref-type="bibr" rid="CR53">53</xref>–<xref ref-type="bibr" rid="CR56">56</xref></sup>.</p><p id="Par5">(±)-Camphor-10-sulfonic acid (CSA) is an effective, water-soluble and reusable organocatalyst that has been used in various organic reactions. For instance, Friedel–Crafts reactions<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>, the synthesis of dioxabicyclo[3.3.1]nonane<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, and the synthesis of spirocyclic compounds<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>.
</p><p id="Par6">The aim of this work is to obtain spiro[benzo[h]quinoline-7,3′-indoline]diones and spiro[indoline-3,4′-pyrazolo[3,4-b]quinoline]diones under ultrasonic irradiation in the presence of ( ±)-CSA catalyst in a H<sub>2</sub>O/EtOH solvent mixture (Figs. <xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig1"><label>Figure 1</label><caption xml:lang="en"><p>Synthesis of compound 4a.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig1_HTML.png" id="MO1"/></fig><fig id="Fig2"><label>Figure 2</label><caption xml:lang="en"><p>Synthesis of compound 6a.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig2_HTML.png" id="MO2"/></fig></p><p id="Par7">To extend the biological curiosity of the synthesized compounds, they were tested for their antibacterial activity against <italic>E. facealis</italic>, <italic>S. aureus</italic>, and <italic>C. albicans</italic>. The radical scavenging activity (determined by DPPH) of these compounds was also investigated. In general, effective HAT agents are compounds that have a high hydrogen atom donating ability and low heteroatom H-bond dissociation energy. Removal of hydrogen from these compounds results in C-centered radicals that are stabilized by resonance or the formation of sterically hindered radicals<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Co-infections in covid 19 pose a high risk, especially in intensive care units<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. In this molecular docking study, <italic>S. aureus</italic> related biotin protein ligase, <italic>E. Facealis</italic> related alanine racemase, and protease N3 complex proteins of covid 19 were selected. In addition, molecular docking simulations were given chractersitics to show their mode of binding energy and the affection of these compounds against Sar-Cov-2 main protease inhibition<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, <italic>Staphylococcus aureus</italic> biotin-protein ligase inhibitor<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, and <italic>E.faecalis</italic> alanine racemase activity<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>.</p></sec><sec id="Sec2"><title>Results and discussion</title><sec id="Sec3"><title>Chemistry</title><p id="Par8">The three-component reaction of isatin (1.00 mmol), 1,3-cyclohexadione (1.00 mmol), and naphthalene-1-amine (1.00 mmol) was used as a model reaction to optimize the reaction conditions. In the presence of %5 mol CSA in H<sub>2</sub>O compound 4a was obtained in 60 min with a yield of 26% under ultrasonic irradiation at room temperature. When the same reaction was examined in the same conditions in a H<sub>2</sub>O/EtOH (3:1, v/v) solvent mixture, the product was obtained with a yield of 74% in 45 min (Table <xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Optimization of ( ±)-CSA catalyst loading in the synthesis of compound 4a.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>( ±)-CSA (mol. %)</p></th><th align="left"><p>Temperature (°C)</p></th><th align="left"><p>Solvent</p></th><th align="left"><p>Conditions</p></th><th align="left"><p>Time (min)</p></th><th align="left"><p>Yield (%)<sup>a</sup></p></th></tr></thead><tbody><tr><td align="left"><p>–</p></td><td char="." align="char"><p>25</p></td><td align="left"><p>EtOH</p></td><td align="left"><p>Stirring</p></td><td char="." align="char"><p>90</p></td><td align="left"><p>Trace</p></td></tr><tr><td align="left"><p>5</p></td><td char="." align="char"><p>25</p></td><td align="left"><p>H<sub>2</sub>O</p></td><td align="left"><p>Stirring</p></td><td char="." align="char"><p>90</p></td><td align="left"><p>Trace</p></td></tr><tr><td align="left"><p>5</p></td><td char="." align="char"><p>25</p></td><td align="left"><p>H<sub>2</sub>O</p></td><td align="left"><p>US</p></td><td char="." align="char"><p>60</p></td><td align="left"><p>26</p></td></tr><tr><td align="left"><p>5</p></td><td char="." align="char"><p>25</p></td><td align="left"><p>H<sub>2</sub>O/EtOH (3:1)</p></td><td align="left"><p>US</p></td><td char="." align="char"><p>45</p></td><td align="left"><p>74</p></td></tr><tr><td align="left"><p>5</p></td><td char="." align="char"><p>50</p></td><td align="left"><p>H<sub>2</sub>O/EtOH (3:1)</p></td><td align="left"><p>US</p></td><td char="." align="char"><p>30</p></td><td align="left"><p>88</p></td></tr><tr><td align="left"><p>10</p></td><td char="." align="char"><p>50</p></td><td align="left"><p>H<sub>2</sub>O/EtOH (3:1)</p></td><td align="left"><p>US</p></td><td char="." align="char"><p>30</p></td><td align="left"><p>89</p></td></tr></tbody></table></table-wrap></p><p id="Par9">When the temperature was increased to 50 °C the product was obtained in 88% yield, and the reaction was completed in 30 min (Table <xref rid="Tab1" ref-type="table">1</xref>). A series of spiro[benzo[<italic>h</italic>]quinoline-7,3′-indoline]diones were synthesized using the optimized reaction conditions under ultrasonic irradiation. The results are summarized in Table <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Synthesis of spiroquinoline-indoline-dione (Spirooxindole) derivatives in the presence of catalyst ( ±)-CSA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="6"><p><inline-graphic xlink:href="MediaObjects/41598_2023_27777_Figa_HTML.gif"/></p></th></tr><tr><th align="left"><p>Entry</p></th><th align="left"><p>Isatin/R</p></th><th align="left"><p>1,3-dicarbonyl compounds</p></th><th align="left"><p>Product</p></th><th align="left"><p>Time (min)</p></th><th align="left"><p>Yield (%)</p></th></tr></thead><tbody><tr><td align="left"><p>1</p></td><td align="left"><p>H</p></td><td align="left"><p>1,3-Cyclohexanedione</p></td><td align="left"><p>4a</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>88</p></td></tr><tr><td align="left"><p>2</p></td><td align="left"><p>H</p></td><td align="left"><p>5,5-Dimethyl-1,3-cyclohexadione</p></td><td align="left"><p>4b*</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>84</p></td></tr><tr><td align="left"><p>3</p></td><td align="left"><p>H</p></td><td align="left"><p>1,3-Cyclopentanedione</p></td><td align="left"><p>4c</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>85</p></td></tr><tr><td align="left"><p>4</p></td><td align="left"><p>H</p></td><td align="left"><p>1,3-Indandione</p></td><td align="left"><p>4d*</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>89</p></td></tr><tr><td align="left"><p>5</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>1,3-Cyclohexanedione</p></td><td align="left"><p>4e</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>85</p></td></tr><tr><td align="left"><p>6</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>5,5-Dimethyl-1,3-cyclohexadione</p></td><td align="left"><p>4f</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>87</p></td></tr><tr><td align="left"><p>7</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>1,3-Cyclopentanedione</p></td><td align="left"><p>4g</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>90</p></td></tr><tr><td align="left"><p>8</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>1,3-Indandione</p></td><td align="left"><p>4h*</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>92</p></td></tr></tbody></table><table-wrap-foot><p>*These compounds were synthesized by another method in the literature<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>.</p></table-wrap-foot></table-wrap></p><p id="Par10">Then the spiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]diones were synthesized via multicomponent reaction of isatins, 5-amino-1-methyl-3-pheylpyrazole, and 1,3-dicarbonyl compounds in the presence of %5 mol ( ±)-CSA in H<sub>2</sub>O/EtOH (3:1, v/v) under ultrasonic irradiation at 50 °C (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption xml:lang="en"><p>Synthesis of spiropyrazolo-indoline-dione (Spirooxindole) derivatives in the presence of catalyst ( ±)-CSA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="6"><p><inline-graphic xlink:href="MediaObjects/41598_2023_27777_Figb_HTML.gif"/></p></th></tr><tr><th align="left"><p>Entry</p></th><th align="left"><p>Isatin/R</p></th><th align="left"><p>1,3-Dicarbonyl compounds</p></th><th align="left"><p>Product</p></th><th align="left"><p>Time (min)</p></th><th align="left"><p>Yield (%)</p></th></tr></thead><tbody><tr><td align="left"><p>1</p></td><td align="left"><p>H</p></td><td align="left"><p>1,3-Cyclohexanedione</p></td><td align="left"><p>6a</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>84</p></td></tr><tr><td align="left"><p>2</p></td><td align="left"><p>H</p></td><td align="left"><p>5,5-Dimethyl-1,3-cyclohexadione</p></td><td align="left"><p>6b</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>87</p></td></tr><tr><td align="left"><p>3</p></td><td align="left"><p>H</p></td><td align="left"><p>1,3-Cyclopentanedione</p></td><td align="left"><p>6c</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>90</p></td></tr><tr><td align="left"><p>4</p></td><td align="left"><p>H</p></td><td align="left"><p>1,3-Indandione</p></td><td align="left"><p>6d</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>89</p></td></tr><tr><td align="left"><p>5</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>1,3-Cyclohexanedione</p></td><td align="left"><p>6e</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>86</p></td></tr><tr><td align="left"><p>6</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>5,5-Dimethyl-1,3-cyclohexadione</p></td><td align="left"><p>6f</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>85</p></td></tr><tr><td align="left"><p>7</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>1,3-Cyclopentanedione</p></td><td align="left"><p>6g</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>91</p></td></tr><tr><td align="left"><p>8</p></td><td align="left"><p>NO<sub>2</sub></p></td><td align="left"><p>1,3-Indandione</p></td><td align="left"><p>6h</p></td><td char="." align="char"><p>30</p></td><td char="." align="char"><p>93</p></td></tr></tbody></table></table-wrap></p><p id="Par11">The structure of the synthesized compounds was confirmed by Fourier transform-infrared (FTIR), <sup>1</sup>H NMR, <sup>13</sup>C, NMR techniques and mass spectroscopy. The NH peaks were observed at 3600–3200 cm<sup>−1</sup> and the C=O peaks were observed at 1730–1670 cm<sup>-1</sup> in the FTIR spectra. In the <sup>1</sup>H NMR spectra of compounds 4a–h and 6a–h, the aliphatic C–H protons resonated at <italic>δ</italic> 1.00–2.97 ppm and the aromatic C–H protons resonated at <italic>δ</italic> 6.40–8.75 ppm, and the N–H protons resonated t <italic>δ</italic> 9.35–11.40 ppm. In the <sup>13</sup>C NMR spectra, the aliphatic carbons resonated at <italic>δ</italic> 18.50–53.00 ppm. The quareternery carbons in spiro moiety resonated at <italic>δ</italic> 47.00–55.00 ppm. The aromatic carbons resonated at <italic>δ</italic> 99.00–168.00 ppm. The carbonyl carbons resonated at <italic>δ</italic> 175.00–200.00 ppm. The mass spectra of all synthesized compounds exhibited the expected molecular ion peak.</p></sec><sec id="Sec4"><title>Antimicrobial activity</title><p id="Par12">The increasing resistance of microorganisms to antibiotics makes it necessary to synthesize compounds that can be used as antibiotics. For this reason, the research of compounds with antimicrobial properties has gained momentum in recent years<sup><xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup>. In this part of the study, the antimicrobial activities of the synthesized spiro[benzo[h]quinoline-7,3′-indoline]dione and spiro[indoline-3,4′-pyrazolo[3,4-b]quinoline]dione derivatives were investigated. For the antimicrobial studies, <italic>E. faecalis</italic> and <italic>S. aureus</italic> were used as bacteria and <italic>C. albicans</italic> as yeast samples. The stock solutions of all compounds used in this study were prepared in DMSO. It was found that some of the compounds showed significant antimicrobial effects (Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption xml:lang="en"><p>Minimal inhibitory concentration (MIC) values of complexes against wild-type microorganisms (μg/ml).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"><p>Compound</p></th><th align="left" colspan="2"><p>Bacteria</p></th><th align="left"><p>Yeast</p></th></tr><tr><th align="left"><p><italic>Enterococcus faecalis ATCC 51,299</italic></p></th><th align="left"><p><italic>Staphylococcus aureus ATCC 25,923</italic></p></th><th align="left"><p><italic>Candida albicans ATCC 10,231</italic></p></th></tr></thead><tbody><tr><td align="left"><p>4a</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4b</p></td><td align="left"><p>750</p></td><td align="left"><p>750</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4c</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4d</p></td><td align="left"><p>3000</p></td><td align="left"><p>1500</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4e</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4f</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4g</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>4h</p></td><td align="left"><p>375</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6a</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6b</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6c</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6d</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6e</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6f</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6g</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>6h</p></td><td align="left"><p>3000</p></td><td align="left"><p>750</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>DMSO</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td><td align="left"><p> &gt; 6000</p></td></tr><tr><td align="left"><p>Gentamicin</p></td><td align="left"><p> &gt; 256</p></td><td align="left"><p>4</p></td><td align="left"><p>ND</p></td></tr><tr><td align="left"><p>Flucanozole</p></td><td align="left"><p>ND</p></td><td align="left"><p>ND</p></td><td align="left"><p>32</p></td></tr></tbody></table></table-wrap></p><p id="Par13">When the MIC values of <italic>E. faecalis</italic> were examined, 4b and 4h showed significant antimicrobial activity. While the MIC value for 4b was 750 μg/mL, this value for 4h was found to be 375 μg/mL. As can be seen here, 4h has a stronger antimicrobial effect on <italic>E. faecalis</italic> than 4b. In addition, other compounds were found to have no antimicrobial effect on <italic>E.faecalis</italic>, but 4b and 4h had significant antimicrobial effect. MIC values were investigated for <italic>S. aureus</italic>, and it was found that these values ranged from 750 to &gt; 6000 μg/ml. Among these compounds, mainly 4b and 4h were observed to have significant antimicrobial activity on <italic>S. aureus</italic>. The MIC values for 4b and 4h were determined to be 750 μg/mL. In addition to these results, no antimicrobial effect was observed for the MIC values of <italic>C. albicans</italic>.</p><p id="Par14">Examination of the obtained results shows that 4b, 4h, and 6h, in particular, have a stronger antimicrobial effect than the other of the synthesized compounds. It was found that 4h showed more activity especially on <italic>E. faecalis</italic>. These results are due to the presence of nitro (NO<sub>2</sub>) group in the synthesized compound series unlike the others. In previous studies on this topic, compounds with similar structures were found to have significant antimicrobial activities<sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. In addition, compounds 4b and 6h have significant antimicrobial effects on <italic>S. aureus</italic>. In the literature, structures similar to these compounds have been shown to have significant antimicrobial effects on <italic>S. aureus</italic><sup><xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref></sup>. <italic>S. aureus</italic> is an important bacterial pathogen in humans that can cause both community-acquired and nosocomial infections and can cause a variety of clinical manifestations including respiratory, urinary, skin, soft tissue, and bloodstream infections<sup><xref ref-type="bibr" rid="CR71">71</xref>,<xref ref-type="bibr" rid="CR72">72</xref></sup>. During the Covid 19 pandemic, some results have shown that <italic>S. aureus</italic> is associated with Covid 19 co-infection<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. It is believed that the synthesized compounds can also be used for this purpose.</p></sec><sec id="Sec5"><title>Time-kill kinetics assay</title><p id="Par15">In the time-killing study, compounds 4b, 4h, and 6h were realised to have the greatest antimicrobial activity. The effects of these compounds on <italic>E. faecalis</italic> and <italic>S. aureus</italic> were studied for 24 h. Figures <xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref>, <xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref> and Table <xref rid="Tab5" ref-type="table">5</xref> show the growth curves and <italic>t99</italic> values of the bacteria as log cfu/mL. The <italic>t99</italic> value is expressed as the time equivalent to 2 log drops. In other words, <italic>t99</italic> refers to the time it takes for the bacterial count to decrease by 100 times the initial density.<fig id="Fig3"><label>Figure 3</label><caption xml:lang="en"><p>Effect of 4b on <italic>E.</italic><italic>faecalis.</italic></p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig3_HTML.png" id="MO5"/></fig><fig id="Fig4"><label>Figure 4</label><caption xml:lang="en"><p>Effect of 4h on <italic>E.</italic><italic>faecalis</italic>.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig4_HTML.png" id="MO6"/></fig><fig id="Fig5"><label>Figure 5</label><caption xml:lang="en"><p>Effect of 4b on <italic>S.</italic><italic>aureus</italic>.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig5_HTML.png" id="MO7"/></fig><fig id="Fig6"><label>Figure 6</label><caption xml:lang="en"><p>Effect of 6h on <italic>S.</italic><italic>aureus</italic>.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig6_HTML.png" id="MO8"/></fig><table-wrap id="Tab5"><label>Table 5</label><caption xml:lang="en"><p><italic>t</italic><sub><italic>99</italic></sub> values of the strains in the MIC, MICx2 and MICx4 concentrations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Strain</p></th><th align="left" colspan="2"><p>Compounds</p></th><th align="left"><p>0.h (log)</p></th><th align="left"><p>24.h (log)</p></th><th align="left"><p><italic>T</italic><sub>99</sub> (h)</p></th></tr></thead><tbody><tr><td align="left" rowspan="7"><p><italic>E.</italic><italic>faecalis</italic></p></td><td align="left" colspan="2"><p>Control (<italic>E.</italic><italic>faecalis</italic>)</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>13.66</p></td><td char="." align="char"><p> &gt; 24</p></td></tr><tr><td align="left" rowspan="3"><p>4b</p></td><td align="left"><p>MIC</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>2.95</p></td><td char="." align="char"><p>10</p></td></tr><tr><td align="left"><p>MICx2</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>2.30</p></td><td char="." align="char"><p>9.09</p></td></tr><tr><td align="left"><p>MICx4</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>0.00</p></td><td char="." align="char"><p>7.14</p></td></tr><tr><td align="left" rowspan="3"><p>4h</p></td><td align="left"><p>MIC</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>4.85</p></td><td char="." align="char"><p>16.6</p></td></tr><tr><td align="left"><p>MICx2</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>3.47</p></td><td char="." align="char"><p>11.1</p></td></tr><tr><td align="left"><p>MICx4</p></td><td char="." align="char"><p>7.79</p></td><td char="." align="char"><p>0.00</p></td><td char="." align="char"><p>7.14</p></td></tr><tr><td align="left" rowspan="7"><p><italic>S.</italic><italic>aureus</italic></p></td><td align="left" colspan="2"><p>Control (<italic>S.</italic><italic>aureus</italic>)</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>13.87</p></td><td char="." align="char"><p> &gt; 24</p></td></tr><tr><td align="left" rowspan="3"><p>4b</p></td><td align="left"><p>MIC</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>3.18</p></td><td char="." align="char"><p>10</p></td></tr><tr><td align="left"><p>MICx2</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>2.94</p></td><td char="." align="char"><p>9.52</p></td></tr><tr><td align="left"><p>MICx4</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>0.00</p></td><td char="." align="char"><p>6.89</p></td></tr><tr><td align="left" rowspan="3"><p>6h</p></td><td align="left"><p>MIC</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>3.90</p></td><td char="." align="char"><p>20</p></td></tr><tr><td align="left"><p>MICx2</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>2.30</p></td><td char="." align="char"><p>11.76</p></td></tr><tr><td align="left"><p>MICx4</p></td><td char="." align="char"><p>6.44</p></td><td char="." align="char"><p>0.00</p></td><td char="." align="char"><p>6.89</p></td></tr></tbody></table></table-wrap></p><p id="Par16">Based on the MIC values of the antimicrobial results, three different MIC values (MIC, MICx2, MICx4) were determined in this study. Figures <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref> show the life graph of <italic>E. faecalis</italic>. As can be seen here, it was found that the number of colonies of <italic>E. faecalis</italic> used as control group increased significantly within 24 h. In addition, it was found that when 4b was added to the medium, there was a significant decrease in the colony number of bacteria within 24 h for MIC, MICx2 and MICx4 values. When the t99 values were examined, it was found that the bacteria in the sample with MIC addition continued to live for 10 h. It was also found that the bacteria survived in the medium with MICx2 addition for 9.09 h and in the medium with MICx4 for 7.14 h. Thus, it was found that the increase in MIC values resulted in a significant decrease in bacterial longevity. Although it was observed that E.faecalis survived more than 24 h in the control sample (without 4h), the survival times were determined to be 16.6 h when 4h was added, 11.1 h when MICx2 was added, and 7.14 h when MICx4 was added. As can be seen here, increasing the MIC value has a significant effect on bacterial longevity.</p><p id="Par17">Compounds 4b and 6h, which are thought to have potent antimicrobial activity on <italic>S. aureus</italic>, form another part of the time-killing study. In this study, bacteria were allowed to live in a nutrient medium for 24 h and colonies were counted at specific time periods. The colony count values were converted to <italic>t99</italic> values, and the survival times of the bacteria were determined. In the study conducted over 24 h, it was found that the number of colonies in the <italic>S. aureus</italic> control sample increased sharply. In the other experimental groups, 4b and 6h were added to the medium as MIC, MICx2 and MICx4, respectively (Figs. <xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref>). For the effect of 4b medium, it was found that <italic>S.aureus</italic> continued to live for 10 h for MIC value, 9.52 h for MICx2 value and 6.89 h for MICx4 value (Table <xref rid="Tab5" ref-type="table">5</xref>). As can be seen here, increasing the MIC value has a negative effect on the bacteria's ability to form colonies and thus on their lifespan (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Serious differences in the colony forming ability of <italic>S. aureus</italic> were also observed in 6 h media with different MIC values. While the bacterium survived more than 24 h in the control sample, it was found that the bacterium survived less than 24 h in the samples to which 6 h was added at MIC, MICx2 and MICx4 values (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). The <italic>t99</italic> values showed that the bacteria survived for 20 h at MIC value, 11.76 h at MICx2 value and 6.89 h at MICx4 value (Table <xref rid="Tab5" ref-type="table">5</xref>).</p><p id="Par18">In summary, it was found that the kill time values (<italic>t99</italic> value) for 4b were effective for approximately the same time for both bacteria at all concentrations. Consequently, the kinetics of kill time and antimicrobial activity results studied at different concentrations are mutually supportive. In fact, similar results were obtained in the study with <italic>S. aureus</italic>.</p></sec><sec id="Sec6"><title>Free radical scavenging activity</title><p id="Par19">DPPH• (1,1-diphenyl-2-picryl-hydrazyl) is a stable free radical that accepts an electron or a hydrogen radical to become a stable diamagnetic molecule. The scavenging effect of the synthesized compounds (4a–h and 6a–h) and standards (BHA, BHT and Trolox) on the DPPH• radical is shown in Fig. <xref rid="Fig7" ref-type="fig">7</xref>.<fig id="Fig7"><label>Figure 7</label><caption xml:lang="en"><p>DPPH radical scavenging activity of synthesized compounds.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig7_HTML.png" id="MO9"/></fig></p><p id="Par20">The results indicate that the synthesized compounds have moderate to good free radical scavenging activity. Moreover, the radical scavenging activity increased with increasing concentration. Higher DPPH radical scavenging activity is associated with lower IC<sub>50</sub> value.</p></sec><sec id="Sec7"><title>Docking study</title><p id="Par21">In this study, molecular docking analysis was performed to evaluate the interaction and affinity of the synthesizing drug candidates towards three proteins: alanine racemase from <italic>E. faecalis</italic> (3E5P), biotin protein ligase from <italic>S. aureus</italic> (3V7R), COVID -19 major protease N3 complex (6LU7). Table <xref rid="Tab6" ref-type="table">6</xref>, <xref rid="Tab7" ref-type="table">7</xref> and <xref rid="Tab8" ref-type="table">8</xref> show the binding energy and major residues to which the ligands bind. The compounds occupied the binding site of the target by hydrophobic interaction, hydrogen bonding, pi-cation interaction and pi-stacking. The hydrogen bonds of the derivatives are retained for most of our compounds, such as LYS40 for biotin-ptorein ligase of <italic>S. aureus</italic>, ARG227 for <italic>E. faecalis</italic>, and GLU166 for Mpro-Sars-Cov2. Compounds 4d, 4f, and 6h with the highest antibacterial activities exhibited strong affinity for the target enzyme with binding energy.<table-wrap id="Tab6"><label>Table 6</label><caption xml:lang="en"><p>The binding affinity of compounds 4a–h and 6a–h with <italic>E. faecalis.</italic></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Compound</p></th><th align="left"><p>Binding energy</p></th><th align="left"><p>Hydrophobic interaction</p></th><th align="left"><p>Hydrogen bond</p></th><th align="left"><p>π-cation interaction</p></th><th align="left"><p>π-stacking</p></th></tr></thead><tbody><tr><td align="left"><p>4a</p></td><td char="." align="char"><p> − 8.02</p></td><td align="left"><p>VAL38, LEU86, ASN206, TYR356</p></td><td align="left"><p>LYS40, TYR44, TYR356</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4b</p></td><td char="." align="char"><p> − 8.48</p></td><td align="left"><p>ASN206, VAL225, TYR356</p></td><td align="left"><p>HIS169</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4c</p></td><td char="." align="char"><p> − 7.91</p></td><td align="left"><p>VAL38, LEU86, ASN206, TYR356</p></td><td align="left"><p>LYS40, TYR44, VAL225, TYR356</p></td><td align="left"><p>LYS40,HIS169</p></td><td align="left"/></tr><tr><td align="left"><p>4d</p></td><td char="." align="char"><p> − 7.85</p></td><td align="left"><p>LEU86, PHE167, ASN206, VAL225, TYR356</p></td><td align="left"><p>LYS40</p></td><td align="left"><p>LYS40,ARG139,HIS169</p></td><td align="left"/></tr><tr><td align="left"><p>4e</p></td><td char="." align="char"><p> − 8.02</p></td><td align="left"><p>ASN206, TYR356</p></td><td align="left"><p>HIS169</p></td><td align="left"><p>LYS40</p></td><td align="left"/></tr><tr><td align="left"><p>4f</p></td><td char="." align="char"><p> − 8.21</p></td><td align="left"><p>ASN206, TYR356</p></td><td align="left"><p>HIS169</p></td><td align="left"><p>LYS40</p></td><td align="left"/></tr><tr><td align="left"><p>4g</p></td><td char="." align="char"><p> − 8.04</p></td><td align="left"><p>VAL38, ASN206</p></td><td align="left"><p>LYS40, ARG139, HIS169</p></td><td align="left"><p>LYS40,ARG139</p></td><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>4h</p></td><td char="." align="char"><p> − 8.79</p></td><td align="left"><p>VAL38, LEU86, ASN206, ARG222, TYR356</p></td><td align="left"><p>HIS169</p></td><td align="left"><p>LYS40</p></td><td align="left"/></tr><tr><td align="left"><p>6a</p></td><td char="." align="char"><p> − 6.96</p></td><td align="left"><p>VAL38, LEU86, ASN206, VAL225</p></td><td align="left"><p>LYS40, TYR44, HIS169</p></td><td align="left"><p>LYS40</p></td><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>6b</p></td><td char="." align="char"><p> − 6.87</p></td><td align="left"><p>VAL38, TYR44, ASN206, ARG222, ILE354, TYR356</p></td><td align="left"><p>LYS40, ARG139, HIS169, ASN206, TYR356</p></td><td align="left"><p>LYS40</p></td><td align="left"><p>TYR356</p></td></tr><tr><td align="left"><p>6c</p></td><td char="." align="char"><p> − 6.40</p></td><td align="left"><p>VAL38, ASN206, TYR356</p></td><td align="left"><p>LYS40, TYR44, VAL225, TYR356</p></td><td align="left"><p>ARG139</p></td><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>6d</p></td><td char="." align="char"><p> − 6.53</p></td><td align="left"><p>VAL38, ASN206, TYR356</p></td><td align="left"><p>LYS40, ARG139, HIS169, TYR356</p></td><td align="left"><p>LYS40</p></td><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>6e</p></td><td char="." align="char"><p> − 7.79</p></td><td align="left"><p>VAL38, LYS40, LEU86, ASN206, VAL225</p></td><td align="left"><p>LYS40, TYR44, HIS169</p></td><td align="left"/><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>6f</p></td><td char="." align="char"><p> − 8.11</p></td><td align="left"><p>LEU86, ASN206</p></td><td align="left"><p>LYS40, TYR44, HIS169, TYR356</p></td><td align="left"/><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>6g</p></td><td char="." align="char"><p> − 8.33</p></td><td align="left"><p>VAL38, LEU86, ASN206, VAL225, TYR356</p></td><td align="left"><p>LYS40, TYR44, ARG139, HIS169</p></td><td align="left"><p>LYS40</p></td><td align="left"><p>HIS169</p></td></tr><tr><td align="left"><p>6h</p></td><td char="." align="char"><p> − 8.63</p></td><td align="left"><p>VAL38, LEU86, ASN206, VAL225, TYR356</p></td><td align="left"><p>LYS40, TYR44, TYR44, HIS169</p></td><td align="left"><p>LYS40,ARG139</p></td><td align="left"><p>HIS169</p></td></tr></tbody></table><table-wrap-foot><p>AlaR (PDB: 3E5P).</p></table-wrap-foot></table-wrap><table-wrap id="Tab7"><label>Table 7</label><caption xml:lang="en"><p>The binding affinity of compounds 4a–h and 6a–h with <italic>Staphylococcus aureus</italic> biotin protein ligase (PDB: 3V7R).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Compound</p></th><th align="left"><p>Binding energy</p></th><th align="left"><p>Hydrophobic interaction</p></th><th align="left"><p>Hydrogen bonds</p></th><th align="left"><p>π-stacking</p></th><th align="left"><p>π-cation interactions</p></th></tr></thead><tbody><tr><td align="left"><p>4a</p></td><td char="." align="char"><p> − 7.59</p></td><td align="left"><p>ARG125, HIS126, TRP127, ILE224</p></td><td align="left"><p>LYS187, ARG227</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4b</p></td><td char="." align="char"><p> − 7.65</p></td><td align="left"><p>ARG125, TRP127, LYS187, ILE224, ALA228</p></td><td align="left"><p>ARG125, LYS187, ARG227</p></td><td align="left"><p>HIS126</p></td><td align="left"/></tr><tr><td align="left"><p>4c</p></td><td char="." align="char"><p> − 7.24</p></td><td align="left"/><td align="left"><p>LYS187, ARG227</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4d</p></td><td char="." align="char"><p> − 7.45</p></td><td align="left"><p>ARG125, TRP127, LYS187, PHE220, ILE224, ALA228</p></td><td align="left"><p>ARG125, ASP180, LYS187, ARG227</p></td><td align="left"><p>HIS126</p></td><td align="left"/></tr><tr><td align="left"><p>4e</p></td><td char="." align="char"><p> − 8.28</p></td><td align="left"><p>ARG125, TRP127, LYS187, ILE224</p></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4f</p></td><td char="." align="char"><p> − 8.26</p></td><td align="left"><p>ARG125, TRP127, LYS187, ILE224, ALA288</p></td><td align="left"><p>SER128, LYS187, ARG227</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4g</p></td><td char="." align="char"><p> − 7.18</p></td><td align="left"><p>ARG125, HIS126, ILE224</p></td><td align="left"><p>ARG227</p></td><td align="left"/><td align="left"><p>ARG125</p></td></tr><tr><td align="left"><p>4h</p></td><td char="." align="char"><p> − 7.59</p></td><td align="left"><p>GLU115, ASP221</p></td><td align="left"/><td align="left"/><td align="left"><p>HIS126</p></td></tr><tr><td align="left"><p>6a</p></td><td char="." align="char"><p> − 5.99</p></td><td align="left"><p>TRP127, LYS187, ILE224</p></td><td align="left"><p>HIS126, LYS187, ARG227</p></td><td align="left"/><td align="left"><p>ARG227</p></td></tr><tr><td align="left"><p>6b</p></td><td char="." align="char"><p> − 6.38</p></td><td align="left"><p>GLN116, SER129, SER130</p></td><td align="left"/><td align="left"><p>HIS126</p></td><td align="left"/></tr><tr><td align="left"><p>6c</p></td><td char="." align="char"><p> − 7.05</p></td><td align="left"><p>TRP127, LYS187, ILE224</p></td><td align="left"><p>HIS126, LYS187, ARG227</p></td><td align="left"/><td align="left"><p>LYS187,ARG227</p></td></tr><tr><td align="left"><p>6d</p></td><td char="." align="char"><p> − 6.11</p></td><td align="left"><p>ARG125, HIS126, TRP127, PHE220, ILE224, ALA228</p></td><td align="left"><p>SER128, LYS187, ARG227</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6e</p></td><td char="." align="char"><p> − 6.73</p></td><td align="left"><p>TRP127, LYS187, ILE224</p></td><td align="left"><p>HIS126, ARG227</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6f.</p></td><td char="." align="char"><p> − 6.32</p></td><td align="left"><p>ARG125, ILE224</p></td><td align="left"><p>HIS126, SER223</p></td><td align="left"><p>HIS126</p></td><td align="left"/></tr><tr><td align="left"><p>6g</p></td><td char="." align="char"><p> − 6.17</p></td><td align="left"><p>HIS126, TRP127, LYS187, ILE224</p></td><td align="left"><p>HIS126, LYS187, ARG227</p></td><td align="left"/><td align="left"><p>LYS187,ARG227</p></td></tr><tr><td align="left"><p>6h</p></td><td char="." align="char"><p> − 8.78</p></td><td align="left"><p>TRP127, ILE224</p></td><td align="left"><p>SER223, ARG227</p></td><td align="left"/><td align="left"/></tr></tbody></table></table-wrap><table-wrap id="Tab8"><label>Table 8</label><caption xml:lang="en"><p>The binding affinity of compounds 4a–h and 6a–h with Mpro-Sars-Cov2 (PDB: 6LU7).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>Compound</p></th><th align="left"><p>Binding energy</p></th><th align="left"><p>Hydrophobic interaction</p></th><th align="left"><p>Hydrogen bond</p></th><th align="left"><p>π-stacking</p></th><th align="left"><p>π-cation interaction</p></th></tr></thead><tbody><tr><td align="left"><p>4a</p></td><td char="." align="char"><p> − 8.22</p></td><td align="left"><p>ASN142, MET165, GLN189</p></td><td align="left"><p>HIS163</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4b</p></td><td char="." align="char"><p> − 8.61</p></td><td align="left"><p>ASP187,GLN189</p></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4c</p></td><td char="." align="char"><p> − 7.67</p></td><td align="left"><p>MET165,GLN189</p></td><td align="left"><p>HIS163,GLU166</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4d</p></td><td char="." align="char"><p> − 8.95</p></td><td align="left"><p>THR25,LEU27,HIS41,MET165,GLU166,GLN189</p></td><td align="left"><p>GLY143</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>4e</p></td><td char="." align="char"><p> − 8.39</p></td><td align="left"><p>HIS41, PHE140, MET165, GLU166, GLN189</p></td><td align="left"><p>GLU166</p></td><td align="left"><p>HIS163</p></td><td align="left"/></tr><tr><td align="left"><p>4f</p></td><td char="." align="char"><p> − 9.04</p></td><td align="left"><p>HIS41, PHE140, MET165, GLU166, GLN189</p></td><td align="left"><p>GLU166</p></td><td align="left"><p>HIS163</p></td><td align="left"/></tr><tr><td align="left"><p>4g</p></td><td char="." align="char"><p> − 7.65</p></td><td align="left"><p>THR25, LEU27, MET165, GLN189</p></td><td align="left"><p>GLY143, GLU166, GLN189</p></td><td align="left"><p>HIS41</p></td><td align="left"><p>HIS41</p></td></tr><tr><td align="left"><p>4h</p></td><td char="." align="char"><p> − 7.62</p></td><td align="left"><p>MET165, ASP187</p></td><td align="left"/><td align="left"><p>HIS41</p></td><td align="left"/></tr><tr><td align="left"><p>6a</p></td><td char="." align="char"><p> − 7.76</p></td><td align="left"><p>MET165, LEU167, GLN192, PRO168</p></td><td align="left"><p>GLU166</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6b</p></td><td char="." align="char"><p> − 8.22</p></td><td align="left"><p>MET165, GLU166, GLN189</p></td><td align="left"><p>HIS41</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6c</p></td><td char="." align="char"><p> − 7.78</p></td><td align="left"><p>MET165,GLN189, LEU167, GLN192</p></td><td align="left"><p>GLU166</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6d</p></td><td char="." align="char"><p> − 8.81</p></td><td align="left"><p>MET165,GLN189, LEU167, GLN192, PRO168</p></td><td align="left"><p>GLU166</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6e</p></td><td char="." align="char"><p> − 7.5</p></td><td align="left"><p>MET165, GLU166, PRO168, GLN189</p></td><td align="left"><p>GLU166, GLU189</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6f</p></td><td char="." align="char"><p> − 7.63</p></td><td align="left"><p>MET165, GLU166, PRO168, GLN189, ALA191</p></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6g</p></td><td char="." align="char"><p> − 6.13</p></td><td align="left"><p>MET165, PRO168, GLN189</p></td><td align="left"><p>GLU166, GLU189</p></td><td align="left"/><td align="left"/></tr><tr><td align="left"><p>6h</p></td><td char="." align="char"><p> − 6.37</p></td><td align="left"><p>ASN180, PRO184, VAL186</p></td><td align="left"><p>PHE181, PHE185</p></td><td align="left"/><td align="left"/></tr></tbody></table></table-wrap></p><p id="Par22">Meanwhile compound 6h and 4b was docked with <italic>S.aureus</italic> protein exhibited the highest binding energy of − 8.78 and − 7.65 kcal/mol respectively. Furthermore hydrogen bond was formed with HIS169 for protein 3E5P, ARG227 for 3V7R, and GLU166 for 6LU7 as illustrated in Fig. <xref rid="Fig8" ref-type="fig">8</xref>.<fig id="Fig8"><label>Figure 8</label><caption xml:lang="en"><p>Docking possition of compounds 4a–h, 6a–h in the active site of 3E5P, 3V7R, 6LU7.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig8a_HTML.png" id="MO10"/><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig8b_HTML.png" id="MO100"/><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig8c_HTML.png" id="MO101"/><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig8d_HTML.png" id="MO102"/></fig></p><p id="Par23">Moreover, compounds 4b, 4h, and 6h had the highest antimicrobial activty and also revealed good binding energies were − 8.79, − 8.63, − 8.48 kcal/mol.</p><p id="Par24">Compounds 6h and 4b, which were docked to the <italic>S. aureus</italic> protein, had the highest binding energy of − 8.78 and 7.65 kcal/mol, respectively. In addition, hydrogen bonds were formed with HIS169 for protein 3E5P, ARG227 for 3V7R, and GLU166 for 6LU7, as shown in Fig. <xref rid="Fig8" ref-type="fig">8</xref> Moreover, compounds 4b, 4h and 6h exhibited the highest antimicrobial activity and also showed good binding energies of − 8.79, − 8.63, − 8.48 kcal/mol, respectively.</p></sec></sec><sec id="Sec8" sec-type="conclusions"><title>Conclusions</title><p id="Par25">In conclusion, spiro[benzo[<italic>h</italic>]quinoline-7,3′-indoline]dione derivatives and spiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]dione derivatives were synthesized via one-pot three-component reactions of isatins, naphthalene-1-amine or 5-amino-1-methyl-3-pheylpyrazole, and 1,3-dicarbonyl compounds in the presence of ( ±)-camphor-10-sulfonic acid in H<sub>2</sub>O/EtOH solvent under ultrasound-promoted conditions. This procedure represents a useful, simple and effective green approach to obtain spiro[benzo[<italic>h</italic>]quinoline-7,3′-indoline]diones and spiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]diones in high yields. The synthesized compounds showed moderate to good free radical scavenging activities.</p><p id="Par26">From the present studies, isatin-based quinoline-pyrazole-indoline hybrids have shown good antimicrobial and antioxidant activities and effects on covid-19.</p><p id="Par27">The antimicrobial activities of these compounds were determined. Compounds 4b, 4h and 6h showed higher activities.</p><p id="Par28">Compound 4b showed promising broad spectrum antibacterial activities against <italic>S. aureus</italic> and <italic>E. faecalis</italic>, which could be attributed to the incorporated alkylated cyclohexanone moiety of spirooxindole.</p><p id="Par29">On the other hand, compound 4h showed significant antibacterial activity against <italic>Enterococcus faecalis</italic> (MIC of 375 µg/mL).</p><p id="Par30">Docking studies for these compounds were performed to gain insight into the mode of action, indicating that the best binding with isatin moiety was all compounds with hydrogen bonds formed by the Lys40, His169 for inhibition of 3E5P, Arg227, His126 for inhibition of 3V7R and GLU166 for inhibition of 6LU7.</p><p id="Par31">Moreover, compounds 4h, 6h, and 4b had the highest antimicrobial activity and also showed good binding energies of − 8.79, − 8.63, − 8.48 kcal/mol, respectively. However, other experimental studies on covid activity may also support docking studies.</p></sec><sec id="Sec9"><title>Experimental</title><sec id="Sec10"><title>Materials and methods</title><p id="Par32">The NMR spectra were recorded on a Bruker Avance III-500 MHz NMR. Chemical shifts are given in ppm downfield from Me<sub>4</sub>Si in DMSO-d<sub>6</sub> solution. Coupling constants are given in Hz. MS spectra were performed on an AB Sciex 3200 QTRAP LC-MS/MS<bold>.</bold> The FTIR spectra were recorded on a Perkin-Elmer FT-IR spectrometer (ATR) and absorption frequencies are reported in cm<sup>−1</sup>. Elemental analyses were performed with CHNS-932 LECO apparatus and were in good agreement (± 0.2%) with the calculated values. Ultrasonication was performed in an Alex Ultrasonic Bath with a frequency of 32 kHz and a power of 230 W. Melting points were measured on a Gallenkamp melting-point apparatus. TLC was performed on standard conversion aluminum sheets pre-coated with a 0.2-mm layer of silica gel. All of the reagents were commercially available.</p></sec><sec id="Sec11"><title>General procedure for the synthesis of compounds (4a–h and 6a–h) under ultrasonic irradiation</title><p id="Par33">CSA (0.05 mmol) was added to a solution of 5-amino-1-methyl-3-phenylpyrazole (1.00 mmol) or 1-naphthylamine (1.00 mmol), isatin (1.00 mmol), and β-diketones (1.00 mmol) in H<sub>2</sub>O/EtOH (3/1, v/v, 8 mL) at room temperature and then the reaction mixture was sonicated at 50 °C for the time indicated in Tables <xref rid="Tab2" ref-type="table">2</xref>, <xref rid="Tab3" ref-type="table">3</xref>. After completion of the reaction, as indicated by TLC monitoring, the resultant solid was washed with water and ethanol and then recrystallized from ethanol to give products 4a–h and 6a–h.</p></sec><sec id="Sec12"><title>10,11-dihydro-8<italic>H</italic>-spiro[benzo[<italic>c</italic>]acridine-7,3′-indoline]-2′,8(9<italic>H</italic>,12<italic>H</italic>)-dione (4a)</title><p id="Par34">White powder, 0.322 g (88%). Mp: 278–281 °C. FTIR (ATR): v = 3362 (N–H), 3295 (N–H), 3059 (aromatic = C–H), 2939 (aliphatic C–H), 1697 (C=O), 1604, 1514 (aromatic C=C), 1499, 1469 (aliphatic C–H), 1333, 1275 (aliphatic C–C), 1086 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.85–1.96 (m, 2H, aliphatic CH<sub>2</sub>), 2.12–2.21 (m, 2H, aliphatic CH<sub>2</sub>), 2.79–2.88 (m, 2H, aliphatic CH<sub>2</sub>), 6.39–7.79 (m, 8H, Ar H), 8.33 (d, <italic>J</italic> = 8.34, 1H, Ar H), 8.50 (d, <italic>J</italic> = 8.49 Hz, 1H, Ar–H), 9.88 (s, 1H, NH), 10.39 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 21.09 (aliphatic CH<sub>2</sub>), 27.21 (aliphatic CH<sub>2</sub>), 36.71 (aliphatic CH<sub>2</sub>), 51.65 (quarternary C), 106.95 (Ar C), 107.21(Ar C), 108.85 (Ar C), 118.52 (Ar C), 121.39 (Ar C), 121.48 (Ar C), 122.11 (Ar C), 123.08 (Ar C), 123.36 (Ar C), 124.15 (Ar C), 126.30 (Ar C), 127.29 (Ar C), 128.02 (Ar C), 129.96 (Ar C), 132.50 (Ar C), 140.33 (Ar C), 141.16 (Ar C), 154.51 (Ar C), 180.98 (C=O), 192.83 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 366, 367; Anal. Calcd for C<sub>24</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>: C, 78.67; H, 4.95; N, 7.65; O, 8.73; Found: C, 78.91; H, 4.78; N, 7.86%.</p></sec><sec id="Sec13"><title>10,10-dimethyl-10,11-dihydro-8<italic>H</italic>-spiro[benzo[<italic>c</italic>]acridine-7,3′-indoline]-2',8(9<italic>H</italic>,12<italic>H</italic>)-dione (4b)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup></title><p id="Par35">White powder, 0.330 g (84%). Mp: 284–286 °C. FTIR (ATR): v = 3516 (N–H), 3252 (N–H), 3008 (aromatic = C–H), 2957 (aliphatic C-H), 1739, 1721 (C=O), 1609, 1592 (aromatic C=C), 1485, 1461 (aliphatic C–H), 1333, 1266 (aliphatic C–C), 1133, 1093 (C–N) cm<sup>−1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.04 (s, 3H, aliphatic CH<sub>3</sub>), 1.07 (s, 3H, aliphatic CH<sub>3</sub>), 2.00 (d, <italic>J</italic> = 16.0 Hz, 1H, aliphatic CH<sub>2</sub>), 2.17 (br s, 1H, aliphatic CH<sub>2</sub>), 2.51 (m, 2H, aliphatic CH<sub>2</sub>), 6.68 (d, <italic>J</italic> = 8.7 Hz, 1H, Ar H), 6.75–6.92 (m, 3H, Ar H), 7.09 (t, <italic>J</italic> = 8.2 Hz, 1H, Ar H), 7.38 (m, 1H, Ar H), 7.53 (t, <italic>J</italic> = 7.4 Hz, 1H, Ar H), 7.61 (t, <italic>J</italic> = 7.6 Hz, 1H, Ar H), 7.79 (d, <italic>J</italic> = 8.1 Hz, 1H, Ar H), 8.49 (d, <italic>J</italic> = 8.6 Hz, 1H, Ar H), 9.35 (s, 1H, NH), 10.40 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 18.50 (aliphatic CH<sub>3</sub>), 27.01 (aliphatic CH<sub>3</sub>), 28.45(aliphatic C(CH<sub>3</sub>)<sub>2</sub>), 32.15 (aliphatic CH<sub>2</sub>), 50.31 (aliphatic CH<sub>2</sub>), 56.01 (quarternary C), 105.94 (Ar C), 108.93 (Ar C), 118.62 (Ar C), 121.39 (Ar C), 122.17 (Ar C), 123.06 (Ar C), 123.19 (Ar C), 124.14 (Ar C), 124.18 (Ar C), 126.02 (Ar C), 126.26 (Ar C), 127.27 (Ar C), 127.99 (Ar C), 130.20 (Ar C), 132.56 (Ar C), 140. 19 (Ar C), 141.26 (Ar C), 152. 56 (Ar C), 180.82 (C=O), 192.48 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 394, 395; Anal. Calcd for C<sub>26</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>: C, 79.16; H, 5.62; N, 7.10; O, 8.11; Found: C, 78.98; H, 5.49; N, 7.27%.</p></sec><sec id="Sec14"><title>9,10-dihydrospiro[benzo[<italic>h</italic>]cyclopenta[<italic>b</italic>]quinoline-7,3'-indoline]-2′,8(11<italic>H</italic>)-dione (4c)</title><p id="Par36">White powder, 0.299 g (85%). Mp: 281–283 °C. FTIR (ATR): v = 3219 (N–H), 3040 (aromatic = C–H), 2955 (aliphatic C–H), 1712 (C=O), 1607, 1515 (aromatic C=C), 1463, 1381 (aliphatic C–H), 1333, 1228 (aliphatic C=C), 1093, 1064 (C-N) cm<sup>−1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 2.29–2.32 (m, 2H, aliphatic CH<sub>2</sub>), 2.88–2.92 (m, 2H, aliphatic CH<sub>2</sub>), 6.85–6.95 (m, 2H, Ar H), 7.12–7.19 (m, 3H, Ar H), 7.41–7.64 (m, 5H), 10.30 (s, 1H, NH), 10.46 (s, 1H) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 24.87 (aliphatic CH<sub>2</sub>), 33.02 (aliphatic CH<sub>2</sub>), 56.02 (quarternary C), 109.22 (Ar C), 110.44 (Ar C), 117.49 (Ar C), 118.42 (Ar C), 121.26 (Ar C), 121.96 (Ar C), 122.69 (Ar C), 123.46 (Ar C), 124.38 (Ar C), 124.84 (Ar C), 126.24 (Ar C), 126.44 (Ar C), 128.09 (Ar C), 131.79 (Ar C), 132.82 (Ar C), 138.24 (Ar C), 141.43 (Ar C), 166.13 (Ar C), 179.38 (C = O), 199.06 (C = O) ppm. MS: <italic>m/z</italic> (ESI): 352, 353; Anal. Calcd for C<sub>23</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>: C, 78.39; H, 4.58; N, 7.95; O, 9.08; Found: C, 78.53; H, 4.46; N, 8.09%.</p></sec><sec id="Sec15"><title>Spiro[benzo[<italic>h</italic>]indeno[1,2-<italic>b</italic>]quinoline-7,3'-indoline]-2',8(13<italic>H</italic>)-dione (4d)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup></title><p id="Par37">Red powder, 0.356 g (89%). Mp: 297–299 °C. FTIR (ATR): v = 3345 (N–H), 3086 (aromatic = C–H), 2912 (aliphatic C–H), 1702 (C=O), 1621, 1590 (aromatic C=C), 1483, 1468 (aliphatic C–H), 1350, 1278 (aliphatic C–C), 1119, 1089 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 6.62–6.79 (m, 3H, Ar H), 6.90–7.12 (m, 4H, Ar H), 7.18–7.70 (m, 4H, Ar H), 7.90–8.70 (m, 3H, Ar H), 10.38 (s, 1H, NH), 10.63 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 52.41 (quarternary C), 109.52 (Ar C), 109.85 (Ar C), 120.09 (Ar C), 120.61 (Ar C), 121.49 (Ar C), 122.18 (Ar C), 123.42 (Ar C), 124.58 (Ar C), 126.51 (Ar C), 126.76 (Ar C), 128.19 (Ar C), 128.30 (Ar C), 128.79 (Ar C), 130.40 (Ar C), 131.36 (Ar C), 132.86 (Ar C), 133.74 (Ar C), 135.88 (Ar C), 136.32 (Ar C), 137.96 (Ar C), 141.41 (Ar C), 142.05 (Ar C), 142.70 (Ar C), 156.02 (Ar C), 175.68 (C = O), 189.15 (C = O) ppm. MS: <italic>m/z</italic> (ESI): 400, 401; Anal. Calcd for C<sub>27</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>: C, 80.99; H, 4.03; N, 7.00; O, 7.99; Found: C, 81.17; H, 4.18; N, 6.88%.</p></sec><sec id="Sec16"><title>5′-nitro-10,11-dihydro-8<italic>H</italic>-spiro[benzo[<italic>c</italic>]acridine-7,3'-indoline]-2′,8(9<italic>H</italic>,12<italic>H</italic>)-dione (4e)</title><p id="Par38">White powder, 0.349 g (85%). Mp: 287–290 °C. FTIR (ATR): v = 3502 (N–H), 3298 (N–H), 3076 (aromatic = C–H), 2946 (aliphatic C–H), 1707 (C=O), 1653, 1621 (aromatic C=C), 1511, 1479 (aliphatic C–H), 1331, 1280 (aliphatic C–C), 1079 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.83–1.96 (m, 2H, aliphatic CH<sub>2</sub>), 2.15–2.24 (m, 2H, aliphatic CH<sub>2</sub>), 2.76–2.92 (m, 2H, aliphatic CH<sub>2</sub>), 6.56–7.65 (m, 7H, Ar H), 8.13–8.54 (m, 2H, Ar H), 10.33 (s, 1H, NH), 11.16 (s, 1H, NH) ppm.<sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 21.45 (aliphatic CH<sub>2</sub>), 27.63 (aliphatic CH<sub>2</sub>), 36.90 (aliphatic CH<sub>2</sub>), 52.22 (quarternary C), 106.76 (Ar C), 109.63 (Ar C), 117.38 (Ar C), 119.12 (Ar C), 122.04 (Ar C), 122.67 (Ar C), 123.56 (Ar C), 124.05 (Ar C), 125.56 (Ar C), 126.83 (Ar C), 127.16 (Ar C), 128.59 (Ar C), 130.71 (Ar C), 133.19 (Ar C), 141.16 (Ar C), 142.65 (Ar C), 148.55 (Ar C), 155.92 (Ar C), 181.78 (C=O), 193.71 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 411, 412; Anal. Calcd for C<sub>24</sub>H<sub>17</sub>N<sub>3</sub>O<sub>4</sub>: C, 70.07; H, 4.16; N, 10.21; O, 15.56; Found: C, 70.23; H, 4.28; N, 10.13%.</p></sec><sec id="Sec17"><title>10,10-dimethyl-5′-nitro-10,11-dihydro-8<italic>H</italic>-spiro[benzo[<italic>c</italic>]acridine-7,3′-indoline]-2′,8(9<italic>H</italic>,12<italic>H</italic>)-dione (4f)</title><p id="Par39">White powder, 0.381 g (87%). Mp: 292–295 °C. FTIR (ATR): v = 3504 (N–H), 3319 (N–H), 3080 (aromatic = C-H), 2956 (aliphatic C-H), 1713 (C = O), 1652, 1625 (aromatic C = C), 1483, 1412 (aliphatic C-H), 1381, 1250 (aliphatic C–C), 1176, 1075 (C-N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.05 (s, 3H, aliphatic CH<sub>3</sub>), 1.08 (s, 3H, aliphatic CH<sub>3</sub>), 1.99–2.21 (m, 2H, aliphatic CH<sub>2</sub>), 2.66–2.75 (m, 2H, aliphatic CH<sub>2</sub>), 6.58–6.65 (m, 3H, Ar H), 7.07–7.56 (m, 3H, Ar H), 7.62–8.50 (m, 3H, Ar H), 10.70 (s, 1H, NH), 11.17 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 27.82 (aliphatic CH<sub>3</sub>), 28.45 (aliphatic CH<sub>3</sub>), 32.79 (aliphatic C(CH<sub>3</sub>)<sub>2</sub>), 50.36 (aliphatic CH<sub>2</sub>), 52.14 (CH<sub>2</sub>), 56.47 (quarternary C), 105.39 (Ar C), 109.73 (Ar C), 117.35 (Ar C), 118.85 (Ar C), 122.03 (Ar C), 122.69 (Ar C), 124.05 (Ar C), 124.21 (Ar C), 125.60 (Ar C), 126.88 (Ar C), 127.18 (Ar C),128.60 (Ar C), 130.85 (Ar C), 133.21 (Ar C), 141.03 (Ar C), 142.60 (Ar C), 148.61 (Ar C), 154.01 (Ar C), 181.69 (C = O), 193.44 (C = O) ppm. MS: <italic>m/z</italic> (ESI): 439, 440; Anal. Calcd for C<sub>26</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub>: C, 71.06; H, 4.82; N, 9.56; O, 14.56; Found: C, 70.91; H, 4.94; N, 9.47%.</p></sec><sec id="Sec18"><title>5′-nitro-9,10-dihydrospiro[benzo[<italic>h</italic>]cyclopenta[<italic>b</italic>]quinoline-7,3′-indoline]-2′,8(11<italic>H</italic>)-dione (4g)</title><p id="Par40">White powder, 0.357 g (90%). Mp: &gt; 300 °C. FTIR (ATR): v = 3208 (N–H), 3032 (aromatic C–H), 2962 (aliphatic C–H), 1718 (C=O), 1605, 1510 (aromatic C=C), 1460, 1380 (aliphatic C–H), 1330, 1226 (aliphatic C–C), 1080, 1065 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 2.26–2.30 (m, 2H, aliphatic CH<sub>2</sub>), 2.79–2.97 (m, 2H, aliphatic CH<sub>2</sub>), 6.58–6.60 (m, 1H, Ar H), 7.12–7.15 (m, 1H, ArH), 7.43–7.45(m, 2H, ArH), 7.64–7.69 (m, 2H, Ar H), 7.83–8.16 (m, 3H, Ar H), 10.52 (s, 1H, NH), 11.28 (s, 1H, NH) ppm.<sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 25.53 (aliphatic CH<sub>2</sub>), 33.39 (aliphatic CH<sub>2</sub>), 51.75 (quarternary C), 109.97 (Ar C), 110.16 (Ar C), 117.20 (Ar C), 120.30 (Ar C), 121.87 (Ar C), 122.62 (Ar C), 123.19 (Ar C), 124.24 (Ar C), 124.93 (Ar C), 126.07 (Ar C), 127.03 (Ar C), 128.69 (Ar C), 132.56 (Ar C), 133.45 (Ar C), 139.03 (Ar C), 142.97 (Ar C), 148.63 (Ar C), 167.24 (Ar C), 180.27 (C = O), 199.87 (C = O) ppm. MS: <italic>m/z</italic> (ESI): 397, 398; Anal. Calcd for C<sub>23</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>: C, 69.52; H, 3.80; N, 10.57; O, 16.10; Found: C, 69.68; H, 3.73; N, 10.37%.</p></sec><sec id="Sec19"><title>5′-nitrospiro[benzo[<italic>h</italic>]indeno[1,2-<italic>b</italic>]quinoline-7,3'-indoline]-2′,8(13<italic>H</italic>)-dione (4h)<sup><xref ref-type="bibr" rid="CR44">44</xref></sup></title><p id="Par41">Red powder, 0.409 g (92%). Mp: &lt; 300 °C. FTIR (ATR): v = 3336 (N–H), 3082 (aromatic C-H), 2918 (aliphatic C-H), 1705 (C=O), 1618, 1586 (aromatic C=C), 1480, 1460 (aliphatic), 1352, 1275 (aliphatic C–C), 1117, 1080 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 6.62–6.97 (m, 3H, Ar H), 7.19–7.43 (m, 3H, Ar H), 7.53–7.62 (m, 3H, Ar H), 7.93–8.55 (m, 4H, Ar H), 10.51 (s, 1H, NH), 11.40 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 52.11 (quaternary C, C-11), 110.44 (Ar C, C-12), 110.61 (Ar C, C-30), 118.82 (Ar C, C-7), 120.62 (Ar C, C-9), 120.77 (Ar C, C-6), 121.53 (Ar C, C-29), 122.52 (Ar C, C-21), 123.33 (Ar C, C-5), 125.04 (Ar C, C-1), 125.64 (Ar C, C-8), 126.32 (Ar C, C-2), 126.89 (Ar C, C-27), 127.54 (Ar C, C-18), 128.74 (Ar C, C-3), 129.72 (Ar C, C-19), 132.12 (Ar C, C-4), 133.54 (Ar C, C-20), 136.70 (Ar C, C-17), 136.92 (Ar C, C-23), 138.80 (Ar C, C-16), 142.08 (Ar C, C-10), 143.20 (Ar C-28), 149.94 (Ar C-24), 156.95 (Ar C, C-13), 176.93 (C=O, C-26), 180.39 (C = O, C-15) ppm. MS: <italic>m/z</italic> (ESI): 445, 446; Anal. Calcd for C<sub>27</sub>H<sub>15</sub>N<sub>3</sub>O<sub>4</sub>: C, 72.80; H, 3.39; N, 9.43; O, 14.37; Found: C, 72.69; H, 3.62; N, 9.30%.</p></sec><sec id="Sec20"><title>1′-methyl-3′-phenyl-6′,7′,8′,9′-tetrahydrospiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]-2,5′(1′<italic>H</italic>)-dione (6a)</title><p id="Par42">White powder, 0.332 g (84%). Mp: 276–279 °C. FTIR (ATR): v = 3356 (N–H), 3238 (N–H), 3006 (aromatic = C–H), 2937 (aliphatic C–H), 1690 (C=O), 1620, 1546 (aromatic C=C), 1493, 1466 (aliphatic C–H), 1324, 1254 (aliphatic C–C), 1135, 1086 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.81–1.93 (m, 2H, aliphatic CH<sub>2</sub>), 2.06–2.17 (m, 2H, aliphatic CH<sub>2</sub>), 2.69 (d, <italic>J</italic> = 4.3 Hz, 2H, aliphatic CH<sub>2</sub>), 3.77 (s, 3H, N–CH<sub>3</sub>), 6.45 (d, <italic>J</italic> = 7.5 Hz, 1H, Ar H), 6.53 (d, <italic>J</italic> = 7.3 Hz, 2H, Ar H), 6.80 (t, <italic>J</italic> = 7.2 Hz, 1H, Ar H), 6.88 (d, <italic>J</italic> = 7.0 Hz, 1H, Ar H), 6.98–7.08 (m, 3H, Ar H), 7.18 (t, <italic>J</italic> = 7.2 Hz, 1H, Ar H), 9.70 (s, 1H, NH), 10.04 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 21.01 (aliphatic CH<sub>2</sub>), 27.72 (aliphatic CH<sub>2</sub>), 35.06 (aliphatic CH<sub>2</sub>), 37.12 (N-CH<sub>3</sub>), 50.12 (quarternary C), 99.81 (Ar C), 108.52 (Ar C), 108.92 (Ar C), 120.90 (Ar C), 123.03 (Ar C), 127.01 (Ar C), 127.06 (Ar C), 127.28 (Ar C), 128.39 (Ar C), 129.12 (Ar C), 132.50 (Ar C), 133.39 (Ar C), 137.23 (Ar C), 138.55 (Ar C), 142.30 (Ar C), 147.02 (Ar C), 153.88 (Ar C), 179.66 (C=O), 193.12 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 396, 397; Anal. Calcd for C<sub>24</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>: C, 72.71; H, 5.08; N, 14.13; O, 8.07; Found: C, 72.30; H, 5.15; N, 13.98%.</p></sec><sec id="Sec21"><title>1′,7′,7′-trimethyl-3′-phenyl-6′,7′,8′,9′-tetrahydrospiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]-2,5′(1′<italic>H</italic>)-dione (6b)</title><p id="Par43">Beige powder, 0.368 g (87%). Mp: 278–281 °C. FTIR (ATR): v = 3618 (N–H), 3320 (N–H), 3087, 3011 (aromatic = C–H), 2988, 2956 (aliphatic C–H), 1682 (C=O), 1629, 1576 (aromatic C=C), 1472, 1406 (aliphatic C–H), 1366, 1320, 1285 (aliphatic C–C), 1196, 1084 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.01 (s, 3H, aliphatic CH<sub>3</sub>), 1.04 (s, 3H, aliphatic CH<sub>3</sub>), 1.96 (d, <italic>J</italic> = 16.0 Hz, 1H, aliphatic CH<sub>2</sub>), 2.08 (d, <italic>J</italic> = 16.1 Hz, 1H, aliphatic CH<sub>2</sub>), 2.51 (dd, <italic>J</italic><sub><italic>1</italic></sub> = 3.5 Hz, <italic>J</italic><sub><italic>2</italic></sub> = 1.8 Hz, 2H, aliphatic CH<sub>2</sub>), 3.78 (s, 3H, N–CH<sub>3</sub>), 6.47 (d, <italic>J</italic> = 7.6 Hz, 1H, Ar H), 6.54–6.57 (m, 2H, Ar H), 6.79–6.83 (m, 1H, Ar H), 6.88 (m, 1H, Ar H), 7.01–7.07 (m, 3H, Ar H), 7.16–7.20 (m, 1H, Ar H), 9.72 (s, 1H, NH), 10.01 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 26.82 (aliphatic CH<sub>3</sub>), 28.13 (aliphatic CH<sub>3</sub>), 32.04 (aliphatic C(CH<sub>3</sub>)<sub>2</sub>), 35.07 (N-CH<sub>3</sub>), 41.00 (aliphatic CH<sub>2</sub>), 49.01 (aliphatic CH<sub>2</sub>), 50.56 (quarternary C), 99.81 (Ar C), 107.64 (Ar C), 108.59 (Ar C), 120.93 (Ar C), 122.91 (Ar C), 123.06 (Ar C), 127.08 (Ar C), 127.29 (Ar C), 128.37 (Ar C), 133.41 (Ar C), 137.37 (Ar C), 138.47 (Ar C), 142.35 (Ar C), 147.02 (Ar C), 151.92 (Ar C), 179.57 (C=O), 192.82 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 424, 425; Anal. Calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub>: C, 73.56; H, 5.70; N, 13.20; O, 7.54; Found: C, 73.62; H, 5.53; N, 13.43%.</p></sec><sec id="Sec22"><title>1-methyl-3-phenyl-6,7-dihydro-1<italic>H</italic>-spiro[cyclopenta[<italic>e</italic>]pyrazolo[3,4-<italic>b</italic>]pyridine-4,3′-indoline]-2′,5(8<italic>H</italic>)-dione (6c)</title><p id="Par44">White powder, 0.343 g (90%). Mp: &gt; 300 °C. FTIR (ATR): v = 3485 (N–H), 3315 (N–H), 3119, 3007 (aromatic = C–H), 2925, 2815 (aliphatic C–H), 1666 (C=O), 1612, 1587 (aromatic C=C), 1487, 1470 (aliphatic C–H), 1357, 1290 (aliphatic C–C gerilmeleri), 1177, 1074 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 2.26 (dd, <italic>J</italic><sub><italic>1</italic></sub> = 10.8 Hz, <italic>J</italic><sub><italic>2</italic></sub> = 5.0 Hz, 2H, aliphatic CH<sub>2</sub>), 2.71–2.80 (m, 2H, aliphatic CH<sub>2</sub>), 3.81 (s, 3H, N–CH<sub>3</sub>), 6.61 (d, <italic>J</italic> = 7.7 Hz, 1H, Ar H), 6.68–6.72 (m, 2H, Ar H), 6.84 (t, <italic>J</italic> = 7.4 Hz, 1H, Ar H), 6.90 (d, <italic>J</italic> = 7.1 Hz, 1H, Ar H), 7.04 (t, <italic>J</italic> = 7.7 Hz, 2H, Ar H), 7.09 (td, <italic>J</italic><sub><italic>1</italic></sub> = 7.6 Hz, <italic>J</italic><sub><italic>2</italic></sub> = 1.1 Hz, 1H, Ar H), 7.16 (t, <italic>J</italic> = 7.4 Hz, 1H, Ar H) 10.13 (s, 1H, NH), 10.83 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 23.95 (aliphatic CH<sub>2</sub>), 33.42 (aliphatic CH<sub>2</sub>), 35.15 (N–CH<sub>3</sub>), 47.74 (quarternary C), 99.58 (Ar C), 108.87 (Ar C), 113.10 (Ar C), 121.44 (Ar C), 123.95 (Ar C), 127.38 (Ar C), 127.70 (Ar C), 128.04 (Ar C), 131.30 (Ar C), 136.47 (Ar C), 139.77 (Ar C), 142.00 (Ar C), 147.15 (Ar C), 166.13 (Ar C), 178.34 (C=O), 198.81 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 382, 383; Anal. Calcd for C<sub>23</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: C, 72.24; H, 4.74; N, 14.65; O, 8.37; Found: C, 72.38; H, 4.53; N, 14.59%.</p></sec><sec id="Sec23"><title>1-methyl-3-phenyl-1<italic>H</italic>-spiro[indeno[2,1-<italic>e</italic>]pyrazolo[3,4-<italic>b</italic>]pyridine-4,3′-indoline]-2′,5(10<italic>H</italic>)-dione (6d)</title><p id="Par45">Red powder, 0.382 g (89%). Mp: &gt; 300 °C. FTIR (ATR): v = 3357 (N–H), 3046, 3020 (aromatic = C–H), 2914 (aliphatic C–H), 1684 (C=O), 1664, 1620 (aromatic C=C), 1483, 1470 (aliphatic C–H), 1340, 1255 (aliphatic C–C), 1070 (C–N) cm<sup>−1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 3.96 (s, 3H, N–CH<sub>3</sub>), 6.67 (d, <italic>J</italic> = 7.3 Hz, 1H, Ar H), 6.78 (m, 2H, Ar H), 6.84 (t, <italic>J</italic> = 7.3 Hz, 1H, ArH), 6.99 (d, <italic>J</italic> = 7.0 Hz, 1H, Ar H), 7.02–7.15 (m, 3H, Ar H), 7.18 (t, <italic>J</italic> = 7.6 Hz, 2H, Ar H), 7.37 (t, <italic>J</italic> = 6.7 Hz, 1H, Ar H), 7.50 (d, <italic>J</italic> = 6.6 Hz, 1H, Ar H), 7.78 (d, <italic>J</italic> = 6.7 Hz, 1H, Ar H), 10.18 (s, 1H, NH), 11.04 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 35.81 (N–CH<sub>3</sub>), 47.46 (quarternary C), 101.05 (Ar C), 106.00 (Ar C), 109.09 (Ar C), 119.65 (Ar C), 120.22 (Ar C), 121.57 (Ar C), 123.09 (Ar C), 123.87 (Ar C), 124.05 (Ar C), 127.16 (Ar C), 127.40 (Ar C), 127.79 (Ar C), 127.94 (Ar C), 130.35 (Ar C), 131.64 (Ar C), 133.15 (Ar C), 133.89 (Ar C), 136.08 (Ar C), 136.36 (Ar C), 139.27 (Ar C), 141.95 (Ar C), 147.50 (Ar C), 155.67 (Ar C), 178.44 (C=O), 188.67 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 430, 431; Anal. Calcd for C<sub>27</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: C, 75.34; H, 4.21; N, 13.02; O, 7.43; Found: C, 75.28; H, 4.11; N, 13.26%.</p></sec><sec id="Sec24"><title>1′-methyl-5-nitro-3′-phenyl-6′,7′,8′,9′-tetrahydrospiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]-2,5′(1′<italic>H</italic>)-dione (6e)</title><p id="Par46">White powder, 0.379 g (86%). Mp: 283–286 °C. FTIR (ATR): v = 3632 (N–H), 3222 (N–H), 3004 (aromatic = C–H), 2943 (aliphatic C–H), 1704 (C=O), 1602, 1595 (aromatic C=C), 1462, 1443 (aliphatic C-H), 1360, 1251 (aliphatic C–C), 1121, 1058 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.87–1.89 (m, 2H, aliphatic CH<sub>2</sub>), 2.12–2.15 (m, 2H, aliphatic CH<sub>2</sub>), 2.68–2.77 (m, 2H, aliphatic CH<sub>2</sub>), 3.79 (s, 3H, N–CH<sub>3</sub>), 6.55 (d, J = 8.6 Hz, 1H, Ar H), 6.59 (d, J = 7.2 Hz, 2H, Ar H), 7.07 (t, J = 7.4 Hz, 2H, Ar H), 7.20 (t, J = 7.1 Hz, 1H, Ar H), 7.66 (s, 1H, Ar H), 7.97 (d, J = 7.0 Hz, 1H, Ar H), 10.27 (s, 1H, NH), 10.48 (s, 1H, NH). <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 21.43 (aliphatic CH<sub>2</sub>), 28.14 (aliphatic CH<sub>2</sub>), 35.73 (aliphatic CH<sub>2</sub>), 37.26 (N-CH<sub>3</sub>), 49.53 (quarternary C), 99.35 (Ar C), 108.29 (Ar C), 108.86 (Ar C), 118.72 (Ar C), 125.16 (Ar C), 127.78 (Ar C), 128.09 (Ar C), 128.62 (Ar C), 128.89 (Ar C), 133.44 (Ar C), 137.71 (Ar C), 139.54 (Ar C), 142.14 (Ar C), 147.50 (Ar C), 155.50 (Ar C), 180.77 (C = O), 193.97 (C = O). MS: <italic>m/z</italic> (ESI): 441, 442; Anal. Calcd for C<sub>24</sub>H<sub>19</sub>N<sub>5</sub>O<sub>4</sub>: C, 65.30; H, 4.34; N, 15.86; O, 14.50; Found: C, 65.47; H, 4.23; N, 15.71%.</p></sec><sec id="Sec25"><title>1′,7′,7′-trimethyl-5-nitro-3′-phenyl-6′,7′,8′,9′-tetrahydrospiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]quinoline]-2,5′(1′<italic>H</italic>)-dione (6f)</title><p id="Par47">White powder, 0.398 g (85%). Mp: 294–297 °C. FTIR (ATR): v = 3646 (N–H), 3318 (N–H), 3017 (aromatic = C–H), 2955 (aliphatic C–H), 1695 (C=O), 1605, 1597 (aromatic C=C), 1475, 1447 (aliphatic C–H), 1337, 1283 (aliphatic C–C), 1190, 1094 (C–N) cm<sup>−1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 1.00 (s, 3H, aliphatic CH<sub>3</sub>), 1.02 (s, 3H, aliphatic CH<sub>3</sub>), 2.02–2.03 (m, 2H, aliphatic CH<sub>2</sub>), 2.55–2.65 (m, 2H, aliphatic CH<sub>2</sub>), 3,79 (s, 3H, N-CH<sub>3</sub>), 6.56 (d, <italic>J</italic> = 8.6 Hz, 1H, Ar H), 6.60 (d, <italic>J</italic> = 7.8 Hz, 2H, Ar H), 7.07 (t, <italic>J</italic> = 7.5 Hz, 2H, Ar H), 7.20 (t, <italic>J</italic> = 7.2 Hz, 1H, Ar H), 7.63 (dd, <italic>J</italic><sub><italic>1</italic></sub> = 7.2 Hz, <italic>J</italic><sub><italic>2</italic></sub> = 2.0 Hz, 1H, Ar H), 7.96–7.98 (dd, <italic>J</italic><sub><italic>1</italic></sub> = 8.5 Hz, <italic>J</italic><sub><italic>2</italic></sub> = 2.0 Hz, 1H, Ar H), 10.23 (s, 1H, NH), 10.50 (s, 1H, NH). <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 27.79 (aliphatic CH<sub>3</sub>), 28.02 (aliphatic CH<sub>3</sub>), 32.66 (aliphatic C(CH<sub>3</sub>)<sub>2</sub>), 35.73 (N-CH<sub>3</sub>), 49.42 (aliphatic CH<sub>2</sub>), 50.69 (aliphatic CH<sub>2</sub>), 56.46 (quarternary C), 99.29 (Ar C), 107.00 (Ar C), 108.92 (Ar C), 118.49 (Ar C), 125.20 (Ar C), 127.80 (Ar C), 128.10 (Ar C), 128.87 (Ar C), 130.62 (Ar C), 133.44 (Ar C), 137.84 (Ar C), 139.46 (Ar C), 142.10 (Ar C), 147.50 (Ar C), 149.36 (Ar C), 153.55 (Ar C), 180.69 (C=O), 193.68 (C=O). MS: <italic>m/z</italic> (ESI): 469, 470; Anal. Calcd for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub>: C, 66.51; H, 4.94; N, 14.92; O, 13.63; Found: C, 66.64; H, 5.03; N, 14.98%.</p></sec><sec id="Sec26"><title>1-methyl-5′-nitro-3-phenyl-6,7-dihydro-1<italic>H</italic>-spiro[cyclopenta[<italic>e</italic>]pyrazolo[3,4-<italic>b</italic>]pyridine-4,3′-indoline]-2′,5(8<italic>H</italic>)-dione (6g)</title><p id="Par48">White powder, 0.388 g (91%). Mp: 277–280 °C. FTIR (ATR): v = 3479 (N–H), 3310 (N–H), 3075, 3025 (aromatic = C–H), 2968, 2934 (aliphatic C–H), 1701, 1667 (C=O), 1612, 1606 (aromatic C=C), 1479, 1448 (aliphatic C–H), 1329, 1297 (aliphatic C=C), 1179, 1067 (C–N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 2.25–2.27 (m, 2H, aliphatic CH<sub>2</sub>), 2.74–2.84 (m, 2H, aliphatic CH<sub>2</sub>), 3.82 (s, 3H, N–CH<sub>3</sub>), 6.71–6.78 (m, 3H, Ar H), 7.02–7.10 (m, 2H, Ar H), 7.17 (t, <italic>J</italic> = 7.3 Hz, 1H, Ar H), 7.68 (d, <italic>J</italic> = 1.8 Hz, 1H, Ar H), 8.02 (dd, J<sub>1</sub> = 8.6 Hz, <italic>J</italic><sub><italic>2</italic></sub> = 2.0 Hz, 1H, Ar H), 10.88 (s, 1H, NH), 11.03 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 24.66 (aliphatic CH<sub>2</sub>), 33.81 (aliphatic CH<sub>2</sub>), 35.77 (N-CH<sub>3</sub>), 48.08 (quarternary C), 99.06 (Ar C), 109.40 (Ar C), 112.29 (Ar C), 119.78 (Ar C), 123.42 (Ar C), 125.75 (Ar C), 128.06 (Ar C), 128.21 (Ar C), 128.74 (Ar C), 133.43 (Ar C), 137.37 (Ar C), 140.35 (Ar C), 142.50 (Ar C), 143.81 (Ar C), 147.66 (Ar C), 148.99 (Ar C), 167.41 (Ar C), 179.53 (C = O), 199.49 (C = O) ppm. MS: <italic>m/z</italic> (ESI): 427, 428; Anal. Calcd for C<sub>23</sub>H<sub>17</sub>N<sub>5</sub>O<sub>4</sub>: C, 64.63; H, 4.01; N, 16.39; O, 14.97; Found: C, 64.52; H, 4.18; N, 16.45%.</p></sec><sec id="Sec27"><title>1-methyl-5′-nitro-3-phenyl-1<italic>H</italic>-spiro[indeno[2,1-<italic>e</italic>]pyrazolo[3,4-<italic>b</italic>]pyridine-4,3′-indoline]-2′,5(10<italic>H</italic>)-dione (6h)</title><p id="Par49">Red powder, 0.441 g (93%). Mp: &gt; 300 °C. FTIR (ATR): v = 3207, 3161 (N–H), 3032, 3013 (aromatic = C–H), 2942 (aliphatic C–H), 1737, 1695 (C=O), 1659, 1622 (aromatic C=C), 1494, 1448 (aliphatic C–H), 1338, 1231 (aliphatic C–C), 1159, 1073 (C-N) cm<sup>-1</sup>. <sup>1</sup>H NMR (d<sub>6</sub>-DMSO, 500 MHz): δ = 3.97 (s, 3H, N-CH<sub>3</sub>), 6.76–6.80 (m, 2H, Ar H), 7.09 (m, 2H, Ar H), 7.19 (m, 2H, Ar H), 7.37 (t, J = 7.3 Hz, 1H, Ar H),7.52 (t, J = 7.3 Hz, 1H, Ar H), 7.81–7.85 (m, 2H, Ar H), 7.93–8.05 (m, 2H, Ar H), 11.00 (s, 1H, NH), 11.36 (s, 1H, NH) ppm. <sup>13</sup>C NMR (d<sub>6</sub>-DMSO, 126 MHz): δ = 36.45 (N–CH<sub>3</sub>), 47.68 (quarternary C), 100.57 (Ar C), 104.81 (Ar C), 109.64 (Ar C), 120.13 (Ar C), 120.65 (Ar C), 120.93 (Ar C), 123.33 (Ar C), 125.94 (Ar C), 128.13 (Ar C), 129.75 (Ar C), 131.14 (Ar C), 132.38 (Ar C), 133.20 (Ar C), 136.40 (Ar C), 136.89 (Ar C), 137.28 (Ar C), 139.88 (Ar C), 142.07 (Ar C), 142.71 (Ar C), 147.92 (Ar C), 148.81 (Ar C), 149.95 (Ar C), 156.88 (Ar C), 179.66 (C=O), 189.18 (C=O) ppm. MS: <italic>m/z</italic> (ESI): 475, 476; Anal. Calcd for C<sub>27</sub>H<sub>17</sub>N<sub>5</sub>O<sub>4</sub>: C, 68.21; H, 3.60; N, 14.73; O, 13.46; Found: C, 68.28; H, 3.66; N, 14.62%.</p></sec><sec id="Sec28"><title>Microdilution method</title><p id="Par50">The antimicrobial study was carried out using the microdilution (MIC) method<sup><xref ref-type="bibr" rid="CR74">74</xref>,<xref ref-type="bibr" rid="CR75">75</xref></sup>. In this study, besides using <italic>Staphylococcus aureus</italic> ATCC 25,923 (<italic>S.aureus</italic>) and <italic>Enterococcus faecalis</italic> (<italic>E.faecalis</italic>) as bacteria, <italic>Candida albicans</italic> ATCC 10,231 (<italic>C.albicans</italic>) was used as yeast. The stock solutions of the complexes were prepared in DMSO and used in all stages of the study. Microorganisms were grown in 5 ml of Nutrient Broth (NB) at 37 °C for 18 h in a shaker incubator. It was taken from the grown bacteria and yeast cells and added to 50 ml of NB. Afterword 10<sup>6</sup> bacteria per ml were obtained in accordance with the 0.5 McFarland turbidity standard. Followed by serial dilution and the serial dilution tubes are incubated at 37 °C for 24 h. The last tube without bacterial growth is accepted as the MIC values. The MIC values were given in μg/ml. Gentamicin and flucanazole were used as control group.</p></sec><sec id="Sec29"><title>Time-kill kinetics assay</title><p id="Par51">After the bacteria were grown in broth (NB) at 37 °C for overnight, they were added to the other sterile broth medium at a rate of approximately 10<sup>5</sup> microorganisms per ml. MIC, MICx2, MICx4 were added to the media prepared separately from the compounds with previously determined MIC values. Colony counts were made on Nutrient Broth medium by taking samples at regular intervals for 24 h from the samples placed in the incubator at 37 °C.</p><p id="Par52">The colony counts were converted into logarithmic values and presented in graphs and Table <xref rid="Tab5" ref-type="table">5</xref>. In addition, the <italic>t</italic><sub><italic>99</italic></sub> values as obtained from the colony counts were defined and the life span of the bacteria was determined. The value <italic>t</italic><sub><italic>99</italic></sub> is calculated as the time corresponding to 2 logarithmic reductions during the 24-h period<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. Compounds 4b, 4h and 6h which were the most effective ones compared to the MIC values were used in the study.</p></sec><sec id="Sec30"><title>Free radical scavenging activity</title><p id="Par53">The free radical scavenging activity was determined by the 1,1-diphenyl-2-picryl-hydrazyl (DPPH•). The activity was measured by following the methodology described by Brand-Williams et al.<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. Briefly, 20 mg/L DPPH• in methanol was prepared and 1.5 mL of this solution was added to 0.75 mL of synthesized compounds solution in methanol at different concentrations (10–400 μg/mL). After 30 min the absorbance was measured at 517 nm. Methanol (0.75 mL) in place of the sample was used as control. Lower absorbance of the reaction mixture indicates higher free radical scavenging activity. The percent inhibition activity was calculated using the following equation:<disp-formula id="Equa"><alternatives><mml:math display="block" id="Equa_Math"><mml:mrow><mml:mrow><mml:mtext>Free radical scavenging effect</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mo>%</mml:mo><mml:mo>=</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>.</mml:mo></mml:mrow></mml:math><tex-math id="Equa_TeX">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym}
				\usepackage{amsfonts}
				\usepackage{amssymb}
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Free radical scavenging effect }}\% = [(A_{0} - A_{1} )/A_{0} ]\times 100.$$\end{document}</tex-math><graphic specific-use="web" mime-subtype="GIF" xlink:href="41598_2023_27777_Article_Equa.gif"/></alternatives></disp-formula> (<italic>A</italic><sub><italic>0</italic></sub> = the control absorbance and <italic>A</italic><sub><italic>1</italic></sub> = the sample solution absorbance).</p></sec><sec id="Sec31"><title>Molecular docking</title><p id="Par54">3V7R and 3E5P were selected as potential target proteins for the antimicrobial activity, and 6LU7 protein for the Sar-Cov-2 main protease inhibition. Known information on the PDB: 3V7R protein shows that the binding strategy of the biotin ligase enzyme of the Staphylococcus aureus protein could be selectively inhibited<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>. The 3E5P as a member of the Alanine racemase (AlaR) is a ubiquitous bacterial enzyme and provides the conversion between L- and D-alanine as the essential cell wall precursor<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>. N3 can specifically, selectivity inhibits Mpro from SARS-CoV and MERS-CoV and has exhibited potent antiviral activity against infectious bronchitis virus<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>.</p><p id="Par55">The crystalline structures of the 32G ((3aS,4S,6aR)-4-(5-{1-[4-(6-amino-9H-purin-9-yl)butyl]-1H-1,2,3-triazol-4-yl}pentyl) complex were downloaded from the PDB IDs 3V7R protein database<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. 3D crystal structure of the PRD_002214 (N-[(5-methylisoxazol-3-yl)carbonyl]alanyl-l-valyl-n ~ 1 ~ -((1r,2z)-4-(benzyloxy)-4-oxo-1-{[(3r)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-l-leucinamide) with SARS-CoV-2 (PDB ID: 6LU7) complex were downloaded from research collaboratory for structural bioinformatics protein data bank (RCSB PDB).</p><p id="Par56">Firstly, each related proteins have been identified as the receptors, the complexed ligands, water as a non-amino acid residues were manually removed from the target proteins using the Discovery Studio Client (Dassault Systems BIOVIA2021), and added hydrogen atoms<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>.</p><p id="Par57">The molecular structure of each compound was drawn accurately using ChemDraw Ultra 12.0, then optimized with the Gaussian G09 program based on density functional level of theory at Becke’s three-parameter Lee–Yang–Parr hybrid functional as B3LYP/6.311 G(d.p) basic set in a vacuum<sup><xref ref-type="bibr" rid="CR83">83</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup>. Through this process was reached the lowest energy or optimized structure of the molecule.</p><p id="Par58">As part of this work, all docking studies were performed using the Autodock 4<sup><xref ref-type="bibr" rid="CR85">85</xref></sup> with the Lamarckian Genetic Algorithm and ten different runs configured to finish after a maximum of 250,000 number of energy assessments were used to obtain the results of the docking experiment.</p><p id="Par59">For the docking validation, simulation of ligand–protein interactions was carried out within Lamarckian genetic algorithms methods and the grid box was set at 40 × 40 × 40 Å in the x, y, z directions with a spacing of 0.375 Å in the active site centre. Each co-crystallized ligand was previously removed from each protein binding site. We compared the predicted docking pose with the experimental co-crystallized binding pose. The small RMSD variation (1.84 Å) was obtained from the re-docking calculations of 6LU7 native ligand, suggesting that the program could correctly and efficiently simulate the experimental results for the respective ligands. The 3V7R receptor crystal with the specified ligands as 32G 3D-crystal was simulated re-docking and the RMSD value was obtained 0.72 Å under this condition. In order to validate the docking approach for the 3E5P protein structure used, the respective co-crystallized ligand, named DCS, was docked to the protein’s active site and docking validation results of the root mean square deviation was obtained 0.82 Å (Fig. <xref rid="Fig9" ref-type="fig">9</xref>).<fig id="Fig9"><label>Figure 9</label><caption xml:lang="en"><p>Validation of the 3V7R and 3E5P proteins, red is native ligand conformation before docking process and blue is native ligand conformation after docking process.</p></caption><graphic specific-use="web" mime-subtype="PNG" xlink:href="MediaObjects/41598_2023_27777_Fig9_HTML.png" id="MO11"/></fig></p></sec></sec></body><back><ack><title>Acknowledgements</title><p>This study was financially supported by Kirklareli University Scientific Research Projects Coordination Unit with the project number KLUBAP 168.</p></ack><sec sec-type="author-contribution"><title>Author contributions</title><p>E.P. and M.G. designed the study; E.P. and G.T. performed synthesis of the samples and free radical scavenging activity studies; E.T.C. and O.I. performed antimicrobial activity studies; M.G. performed molecular docking studies; E.P., M.G. and O.I. writing-review and editing the manuscript; All authors have read and agreed to the published version of the manuscript.</p></sec><sec sec-type="data-availability"><title>Data availability</title><p>The data used to support the findings of this study are included within the article and supplementary materials.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1" sec-type="COI-statement"><title>Competing interests</title><p id="Par60">The authors declare no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name></person-group><source>Multicomponent Reactions in Organic Synthesis</source><year>2015</year><publisher-name>Wiley-VCH</publisher-name><fpage>521</fpage></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ameta</surname><given-names>K</given-names></name><name><surname>Dandia</surname><given-names>A</given-names></name></person-group><source>Multicomponent Reactions: Synthesis of Bioactive Heterocycles</source><year>2017</year><publisher-name>CRC Press</publisher-name><pub-id pub-id-type="doi">10.1201/9781315369754</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trost</surname><given-names>BM</given-names></name></person-group><article-title xml:lang="en">The atom economy—A search for synthetic efficiency</article-title><source>Science</source><year>1991</year><volume>254</volume><issue>5037</issue><fpage>1471</fpage><lpage>1477</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">1991Sci...254.1471T</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK38XlvVegsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1126/science.1962206</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liou</surname><given-names>YC</given-names></name><name><surname>Lin</surname><given-names>YA</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>JC</given-names></name><name><surname>Jang</surname><given-names>YJ</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name></person-group><article-title xml:lang="en">Synthesis of novel <italic>Spiro</italic>-tetrahydroquinoline derivatives and evaluation of their pharmacological effects on wound healing</article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><issue>12</issue><fpage>6251</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhslCltbrI</pub-id><pub-id pub-id-type="doi">10.3390/ijms22126251</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Ritika</surname></name></person-group><article-title xml:lang="en">A brief review of the biological potential of indole derivatives</article-title><source>Future J. Pharm. Sci.</source><year>2020</year><volume>6</volume><fpage>121</fpage><pub-id pub-id-type="doi">10.1186/s43094-020-00141-y</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>MA</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name><name><surname>Askar</surname><given-names>AA</given-names></name><name><surname>El-Khalafawy</surname><given-names>A</given-names></name><name><surname>Makhlouf</surname><given-names>AH</given-names></name></person-group><article-title xml:lang="en">One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor</article-title><source>Eur. J. Med. Chem.</source><year>2020</year><volume>188</volume><fpage>1119772</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtFCjtbk%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111977</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ammar</surname><given-names>YA</given-names></name><name><surname>AbdEl-Hafez</surname><given-names>SMA</given-names></name><name><surname>Hessein</surname><given-names>SA</given-names></name><name><surname>Ali</surname><given-names>AM</given-names></name><name><surname>Askar</surname><given-names>AA</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">One-pot strategy for thiazole tethered 7-ethoxy quinoline hybrids: Synthesis and potential antimicrobial agents as dihydrofolate reductase (DHFR) inhibitors with molecular docking study</article-title><source>J. Mol. Struct.</source><year>2021</year><volume>1242</volume><fpage>130748</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhsFKgtbbE</pub-id><pub-id pub-id-type="doi">10.1016/j.molstruc.2021.130748</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubica</surname><given-names>K</given-names></name><name><surname>Taciak</surname><given-names>P</given-names></name><name><surname>Czajkowska</surname><given-names>A</given-names></name><name><surname>Ignasiak</surname><given-names>AS</given-names></name><name><surname>Wyrebiak</surname><given-names>R</given-names></name><name><surname>Podsadni</surname><given-names>P</given-names></name><name><surname>Bia£y</surname><given-names>IM</given-names></name><name><surname>Malejczyk</surname><given-names>J</given-names></name><name><surname>Mazurek</surname><given-names>AP</given-names></name></person-group><article-title xml:lang="en">Synthesis and anticancer activity evaluation of some new derivatives of 2-(4-benzoyl-1-piperazinyl)-quinoline and 2-(4-cinnamoyl-1-piperazinyl)-quinoline</article-title><source>Acta Pol. Pharm. Drug Res</source><year>2018</year><volume>75</volume><fpage>891</fpage><lpage>901</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhtlKit7bF</pub-id><pub-id pub-id-type="doi">10.32383/appdr/80098</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benard</surname><given-names>C</given-names></name><name><surname>Zouhiri</surname><given-names>F</given-names></name><name><surname>Normand-Bayle</surname><given-names>M</given-names></name><name><surname>Danet</surname><given-names>M</given-names></name><name><surname>Desmaele</surname><given-names>D</given-names></name><name><surname>Leh</surname><given-names>H</given-names></name><name><surname>Mauscadet</surname><given-names>JF</given-names></name><name><surname>Mbemba</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>CM</given-names></name><name><surname>Bonnenfant</surname><given-names>S</given-names></name><name><surname>Le Bret</surname><given-names>M</given-names></name><name><surname>d’Angela</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Linker-modified quinoline derivatives targeting HIV-1 integrase: Synthesis and biological activity</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2004</year><volume>14</volume><fpage>2473</fpage><lpage>2476</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2cXjsVKhtrs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bmcl.2004.03.005</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>H-G</given-names></name><name><surname>Li</surname><given-names>Z-W</given-names></name><name><surname>Hu</surname><given-names>X-X</given-names></name><name><surname>Si</surname><given-names>S-Y</given-names></name><name><surname>You</surname><given-names>X-F</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y-X</given-names></name><name><surname>Song</surname><given-names>D-Q</given-names></name></person-group><article-title xml:lang="en">Synthesis and biological evaluation of quinoline derivatives as a novel class of broad-spectrum antibacterial agents</article-title><source>Molecules</source><year>2019</year><volume>24</volume><issue>3</issue><fpage>548</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXot1KntLk%3D</pub-id><pub-id pub-id-type="doi">10.3390/molecules24030548</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>P</given-names></name><name><surname>Verma</surname><given-names>P</given-names></name><name><surname>Deshpande</surname><given-names>S</given-names></name><name><surname>Saxena</surname><given-names>JK</given-names></name><name><surname>Srivastava</surname><given-names>K</given-names></name><name><surname>Chauhan</surname><given-names>PMS</given-names></name><name><surname>Prabhakar</surname><given-names>YS</given-names></name></person-group><article-title xml:lang="en">N-(7-chloroquinolinyl-4-aminoalkyl)arylsulfonamides as antimalarial agents: rationale for the activity with reference to inhibition of hemozoin formation</article-title><source>RSC Adv.</source><year>2016</year><volume>6</volume><issue>30</issue><fpage>25584</fpage><lpage>25593</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2016RSCAd...625584V</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xjt1Citr0%3D</pub-id><pub-id pub-id-type="doi">10.1039/C6RA00846A</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>C-H</given-names></name><name><surname>Tung</surname><given-names>C-W</given-names></name><name><surname>Wu</surname><given-names>C-H</given-names></name><name><surname>Tzeng</surname><given-names>C-C</given-names></name><name><surname>Chen</surname><given-names>Y-H</given-names></name><name><surname>Hwang</surname><given-names>T-L</given-names></name><name><surname>Chen</surname><given-names>Y-L</given-names></name></person-group><article-title xml:lang="en">Discovery of indeno[1,2-<bold>c</bold>]quinoline derivatives as potent dual antituberculosis and anti-inflammatory agents</article-title><source>Molecules</source><year>2017</year><volume>22</volume><issue>6</issue><fpage>1001</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhsVGgtLvL</pub-id><pub-id pub-id-type="doi">10.3390/molecules22061001</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>H</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Narasimhan</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Indole hybridized diazenyl derivatives: Synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies</article-title><source>BMC Chem.</source><year>2019</year><volume>13</volume><issue>1</issue><fpage>65</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhtFert77F</pub-id><pub-id pub-id-type="doi">10.1186/s13065-019-0580-0</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Ultrasound-assisted, one-pot, three-component synthesis and antibacterial activities of novel indole derivatives containing 1,3,4-oxadiazole and 1,2,4-triazole moieties</article-title><source>Comptes Rendus Chim.</source><year>2015</year><volume>18</volume><fpage>1320</fpage><lpage>1327</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhslansLzM</pub-id><pub-id pub-id-type="doi">10.1016/j.crci.2015.09.005</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugwu</surname><given-names>DI</given-names></name><name><surname>Okoro</surname><given-names>UC</given-names></name><name><surname>Ukoha</surname><given-names>PO</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Okafor</surname><given-names>SN</given-names></name></person-group><article-title xml:lang="en">Novel anti-inflammatory and analgesic agents: Synthesis, molecular docking and in vivo studies</article-title><source>J. Enzyme Inhib. Med. Chem.</source><year>2018</year><volume>33</volume><issue>1</issue><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXitVSlsbvI</pub-id><pub-id pub-id-type="doi">10.1080/14756366.2018.1426573</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ustundag</surname><given-names>CG</given-names></name><name><surname>Gursoy</surname><given-names>E</given-names></name><name><surname>Naesens</surname><given-names>L</given-names></name><name><surname>Guzeldemirci</surname><given-names>NU</given-names></name><name><surname>Çapan</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones</article-title><source>Bioorg. Med. Chem.</source><year>2016</year><volume>24</volume><fpage>240</fpage><lpage>246</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXitVKju7%2FO</pub-id><pub-id pub-id-type="doi">10.1016/j.bmc.2015.12.008</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YY</given-names></name><name><surname>Wu</surname><given-names>HS</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>CR</given-names></name><name><surname>Yu</surname><given-names>JH</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>YS</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>He</surname><given-names>QJ</given-names></name></person-group><article-title xml:lang="en">The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo</article-title><source>Pharmacol. Res.</source><year>2007</year><volume>56</volume><issue>4</issue><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXhtFekt7%2FJ</pub-id><pub-id pub-id-type="doi">10.1016/j.phrs.2007.08.002</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queiroz</surname><given-names>MJRP</given-names></name><name><surname>Abreu</surname><given-names>AS</given-names></name><name><surname>Carvalho</surname><given-names>MSD</given-names></name><name><surname>Ferreira</surname><given-names>PMT</given-names></name><name><surname>Nazareth</surname><given-names>N</given-names></name><name><surname>Sao-Jose Nascimento</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Synthesis of new heteroaryl and heteroannulated indoles from dehydrophenylalanines: Antitumor evaluation</article-title><source>Bioorg. Med. Chem.</source><year>2008</year><volume>16</volume><issue>10</issue><fpage>5584</fpage><lpage>5589</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1cXmsVamsro%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bmc.2008.04.004</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousif</surname><given-names>MNM</given-names></name><name><surname>Hussein</surname><given-names>HAR</given-names></name><name><surname>Yousif</surname><given-names>NM</given-names></name><name><surname>El-Manawaty</surname><given-names>MA</given-names></name><name><surname>El-Sayed</surname><given-names>WA</given-names></name></person-group><article-title xml:lang="en">Synthesis and anticancer activity of novel 2-phenylindole linked imidazolothiazole, thiazolo-s-triazine and imidazolyl-sugar systems</article-title><source>J. Appl. Pharm. Sci.</source><year>2019</year><volume>9</volume><issue>1</issue><fpage>6</fpage><lpage>14</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXit1yls7fJ</pub-id><pub-id pub-id-type="doi">10.7324/JAPS.2019.90102</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parthasarathy</surname><given-names>K</given-names></name><name><surname>Praveen</surname><given-names>C</given-names></name><name><surname>Jeyaveeran</surname><given-names>JC</given-names></name><name><surname>Prince</surname><given-names>AAM</given-names></name></person-group><article-title xml:lang="en">Gold catalyzed double condensation reaction: Synthesis, antimicrobial and cytotoxicity of spirooxindole derivatives</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><issue>17</issue><fpage>4310</fpage><lpage>4317</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28Xht1Kmtb7N</pub-id><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.07</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>G</given-names></name><name><surname>Manoj Modi</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name></person-group><article-title xml:lang="en">Rhodium(II) acetate-catalyzed stereoselective synthesis, SAR and anti-HIV activity of novel oxindoles bearing cyclopropane ring</article-title><source>Eur. J. Med. Chem.</source><year>2011</year><volume>46</volume><issue>4</issue><fpage>1181</fpage><lpage>1188</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXjsFWhtb4%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ejmech.2011.01.037</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Kalyoubi</surname><given-names>SA</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name><name><surname>Abu Ali</surname><given-names>OA</given-names></name><name><surname>Ammar</surname><given-names>YA</given-names></name><name><surname>Seadawy</surname><given-names>MG</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Fayed</surname><given-names>EA</given-names></name></person-group><article-title xml:lang="en">One-pot synthesis and molecular modeling studies of new bioactive spiro-oxindoles based on uracil derivatives as SARS-CoV-2 inhibitors targeting RNA polymerase and spike glycoprotein</article-title><source>Pharmaceuticals</source><year>2022</year><volume>15</volume><fpage>376</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB38XoslSjsL8%3D</pub-id><pub-id pub-id-type="doi">10.3390/ph15030376</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eldeeb</surname><given-names>M</given-names></name><name><surname>Sanad</surname><given-names>EF</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name><name><surname>Ammar</surname><given-names>YA</given-names></name><name><surname>Mahmoud</surname><given-names>K</given-names></name><name><surname>Ali</surname><given-names>MM</given-names></name><name><surname>Hamdy</surname><given-names>NM</given-names></name></person-group><article-title xml:lang="en">Anticancer effects with molecular docking confirmation of newly synthesized isatin sulfonamide molecular hybrid derivatives against hepatic cancer cell lines</article-title><source>Biomedicines</source><year>2022</year><volume>10</volume><fpage>722</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB38XosVOks7k%3D</pub-id><pub-id pub-id-type="doi">10.3390/biomedicines10030722</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendre</surname><given-names>DB</given-names></name><name><surname>Toche</surname><given-names>RB</given-names></name><name><surname>Jachak</surname><given-names>MN</given-names></name></person-group><article-title xml:lang="en">Synthesis of novel dipyrazolo[3,4-b:3,4-d]pyridines and study of their fluorescence behavior</article-title><source>Tetrahedron</source><year>2007</year><volume>63</volume><issue>45</issue><fpage>11000</fpage><lpage>11004</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXhtFSisLrF</pub-id><pub-id pub-id-type="doi">10.1016/j.tet.2007.08.052</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schönhaber</surname><given-names>J</given-names></name><name><surname>Müller</surname><given-names>TJJ</given-names></name></person-group><article-title xml:lang="en">Luminescent bichromophoric spiroindolones—Synthesis and electronic properties</article-title><source>Org. Biomol. Chem.</source><year>2011</year><volume>9</volume><issue>18</issue><fpage>6196</fpage><lpage>6199</lpage><pub-id pub-id-type="doi">10.1039/C1OB05703K</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Rani</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Pyrazole containing anti-HIV agents: An update</article-title><source>Med. Chem.</source><year>2022</year><volume>18</volume><issue>8</issue><fpage>831</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.2174/1573406418666220106163846</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Nikolovska-Coleska</surname><given-names>Z</given-names></name><name><surname>Qiu</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Stuckey</surname><given-names>J</given-names></name><name><surname>Krajewski</surname><given-names>K</given-names></name><name><surname>Roller</surname><given-names>PP</given-names></name><name><surname>Tomita</surname><given-names>Y</given-names></name><name><surname>Parrish</surname><given-names>DA</given-names></name><name><surname>Deschamps</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Structure-based design of potent non-peptide MDM2 inhibitors</article-title><source>J. Am. Chem. Soc.</source><year>2005</year><volume>127</volume><issue>29</issue><fpage>10130</fpage><lpage>10131</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXls1ahtL0%3D</pub-id><pub-id pub-id-type="doi">10.1021/ja051147z</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagender</surname><given-names>P</given-names></name><name><surname>Naresh Kumar</surname><given-names>R</given-names></name><name><surname>Malla Reddy</surname><given-names>G</given-names></name><name><surname>Krishna Swaroop</surname><given-names>D</given-names></name><name><surname>Poornachandra</surname><given-names>Y</given-names></name><name><surname>Ganesh Kumar</surname><given-names>C</given-names></name><name><surname>Narsaiah</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><fpage>4427</fpage><lpage>4432</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhtlCiur3J</pub-id><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.08.006</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quiroga</surname><given-names>J</given-names></name><name><surname>Villarreal</surname><given-names>Y</given-names></name><name><surname>Galvez</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>A</given-names></name><name><surname>Insuasty</surname><given-names>B</given-names></name><name><surname>Abonia</surname><given-names>R</given-names></name><name><surname>Raimondi</surname><given-names>M</given-names></name><name><surname>Zacchino</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Synthesis and antifungal in vitro evaluation of pyrazolo[3,4-b]pyridines derivatives obtained by Aza-Diels–Alder reaction and microwave irradiation</article-title><source>Chem. Pharm. Bull.</source><year>2017</year><volume>65</volume><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtVKnu7rE</pub-id><pub-id pub-id-type="doi">10.1248/cpb.c16-00652</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>MS</given-names></name><name><surname>Ali</surname><given-names>MA</given-names></name></person-group><article-title xml:lang="en">Novel pyrazolo[3,4-b]pyridine derivatives: Synthesis, characterization, antimicrobial and antiproliferative profile</article-title><source>Biol. Pharm. Bull.</source><year>2016</year><volume>39</volume><issue>4</issue><fpage>473</fpage><lpage>483</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhsVyku7fN</pub-id><pub-id pub-id-type="doi">10.1248/bpb.b15-00586</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayman</surname><given-names>R</given-names></name><name><surname>Radwan</surname><given-names>AM</given-names></name><name><surname>Elmetwally</surname><given-names>AM</given-names></name><name><surname>Ammar</surname><given-names>YA</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation</article-title><source>Arch. Pharm.</source><year>2022</year><pub-id pub-id-type="doi">10.1002/ardp.202200395</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzahrani</surname><given-names>AY</given-names></name><name><surname>Ammar</surname><given-names>YA</given-names></name><name><surname>Salem</surname><given-names>MA</given-names></name><name><surname>Abu-Elghait</surname><given-names>M</given-names></name><name><surname>Ragab</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Design, synthesis, molecular modeling, and antimicrobial potential of novel 3-[(1<italic>H</italic>-pyrazol-3-yl)imino]indolin-2-one derivatives as DNA gyrase inhibitors</article-title><source>Arch. Pharm.</source><year>2022</year><volume>355</volume><fpage>e2100266</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXisVegsrrF</pub-id><pub-id pub-id-type="doi">10.1002/ardp.202100266</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Ji</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Efficient one-pot synthesis of spirooxindole derivatives catalyzed by L-proline in aqueous medium</article-title><source>J. Comb. Chem.</source><year>2010</year><volume>12</volume><issue>2</issue><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXnvFWlsg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1021/cc9001185</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shakibaei</surname><given-names>GI</given-names></name><name><surname>Feiz</surname><given-names>A</given-names></name><name><surname>Bazgir</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">A simple and catalyst-free three-component method for the synthesis of spiro[indenopyrazolopyridine indoline]diones and spiro[indenopyridopyrimidine indoline]triones</article-title><source>Comptes Rendus Chim.</source><year>2011</year><volume>14</volume><issue>6</issue><fpage>556</fpage><lpage>562</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXnsVCgs7c%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.crci.2010.10.001</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balamurugan</surname><given-names>K</given-names></name><name><surname>Perumal</surname><given-names>S</given-names></name><name><surname>Menendez</surname><given-names>JC</given-names></name></person-group><article-title xml:lang="en">New four-component reactions in water: A convergent approach to the metal-free synthesis of spiro[indoline/acenaphthylene-3,4′-pyrazolo[3,4-b]pyridine derivatives</article-title><source>Tetrahedron</source><year>2011</year><volume>67</volume><issue>18</issue><fpage>3201</fpage><lpage>3208</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXksFKmt78%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.tet.2011.03.020</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Ling</surname><given-names>Z</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Rong</surname><given-names>L</given-names></name><name><surname>Tu</surname><given-names>SJ</given-names></name></person-group><article-title xml:lang="en">Green synthesis of novel spiro[indoline-3,4′-pyrazolo[3,4-b]pyridine]-2,3′(7′H)-dione, spiro[indeno[1,2-b]pyrazolo[4,3-e]pyridine-4,3′-indoline]-2′,3-dione, and spiro[benzo[h]pyrazolo[3,4-b]quinoline-7,3′-indoline]-2′,8(5H)-dione derivatives in aqueous medium</article-title><source>Tetrahedron</source><year>2017</year><volume>73</volume><issue>4</issue><fpage>385</fpage><lpage>394</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XitFClsbnJ</pub-id><pub-id pub-id-type="doi">10.1016/j.tet.2016.12.015</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danel</surname><given-names>A</given-names></name><name><surname>Wojtasik</surname><given-names>K</given-names></name><name><surname>Szlachcic</surname><given-names>P</given-names></name><name><surname>Gryl</surname><given-names>M</given-names></name><name><surname>Stadnicka</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">A new regiospecific synthesis method of 1<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]quinoxalines—Potential materials for organic optoelectronic devices, and a revision of an old scheme</article-title><source>Tetrahedron</source><year>2017</year><volume>73</volume><fpage>5072</fpage><lpage>5081</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtFCgsLjN</pub-id><pub-id pub-id-type="doi">10.1016/j.tet.2017.06.061</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meena</surname><given-names>K</given-names></name><name><surname>Kumari</surname><given-names>S</given-names></name><name><surname>Khurana</surname><given-names>JM</given-names></name><name><surname>Malik</surname><given-names>A</given-names></name><name><surname>Sharma</surname><given-names>C</given-names></name><name><surname>Panwar</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">One pot three component synthesis of spiro[indolo-3,10′-indeno[1,2-<italic>b</italic>]quinolin]-2,4,11′-triones as a new class of antifungal and antimicrobial agents</article-title><source>Chin. Chem. Lett.</source><year>2017</year><volume>28</volume><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC28XhtFSgtbjK</pub-id><pub-id pub-id-type="doi">10.1016/j.cclet.2016.06.025</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mondal</surname><given-names>A</given-names></name><name><surname>Mukhopadhyay</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">FeCl<sub>3</sub>-catalyzed combinatorial synthesis of functionalized spiro[indolo-3,10′-indeno [1,2-b]quinolin]-trione derivatives</article-title><source>ACS Comb. Sci.</source><year>2015</year><volume>17</volume><issue>7</issue><fpage>404</fpage><lpage>408</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhtVagu7jE</pub-id><pub-id pub-id-type="doi">10.1021/acscombsci.5b00038</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelit</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Synthesis of isoxazolopyridines and spirooxindoles under ultrasonic irradiation and evaluation of their antioxidant activity</article-title><source>J. Chem.</source><year>2017</year><volume>9161505</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXkt1ejtrc%3D</pub-id><pub-id pub-id-type="doi">10.1155/2017/9161505</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Banna</surname><given-names>MG</given-names></name><name><surname>El-Hashash</surname><given-names>MA</given-names></name><name><surname>Elnaggar</surname><given-names>AM</given-names></name><name><surname>El-Badawy</surname><given-names>AA</given-names></name><name><surname>Rizk</surname><given-names>SA</given-names></name></person-group><article-title xml:lang="en">An efficient ultrasonic synthetic approach, DFT study, and molecular docking of 6a-hydroxy-9-nitro-6,6a-dihydro-isoindolo[2,1-a]quinazoline-5,11-dione derivatives as algaecides for refining wastewater</article-title><source>J. Heterocycl. Chem.</source><year>2021</year><volume>58</volume><issue>7</issue><fpage>1502</fpage><lpage>1514</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhtF2ntrzI</pub-id><pub-id pub-id-type="doi">10.1002/jhet.4276</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attia</surname><given-names>SK</given-names></name><name><surname>Elgendy</surname><given-names>AT</given-names></name><name><surname>Rizk</surname><given-names>SA</given-names></name></person-group><article-title xml:lang="en">Efficient green synthesis of antioxidant azacoumarin dye bearing spiro-pyrrolidine for enhancing electro-optical properties of perovskite solar cells</article-title><source>J. Mol. Struct.</source><year>2019</year><volume>1184</volume><fpage>583</fpage><lpage>592</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2019JMoSt1184..583A</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXktV2lsbs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.molstruc.2019.02.042</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizk</surname><given-names>SA</given-names></name><name><surname>Abdelwahab</surname><given-names>SS</given-names></name><name><surname>Sallam</surname><given-names>AH</given-names></name></person-group><article-title xml:lang="en">Regioselective reactions, spectroscopic characterization, and cytotoxic evaluation of spiro-pyrrolidine thiophene</article-title><source>J. Heterocycl. Chem.</source><year>2018</year><volume>55</volume><issue>7</issue><fpage>1604</fpage><lpage>1614</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhtVGisrnF</pub-id><pub-id pub-id-type="doi">10.1002/jhet.3195</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmati</surname><given-names>A</given-names></name><name><surname>Vashareh</surname><given-names>ME</given-names></name></person-group><article-title xml:lang="en">Synthesis of spiro[benzo[<italic>h</italic>]quinoline-7,3-indolines] via a three-component condensation reaction</article-title><source>J. Chem. Sci.</source><year>2014</year><volume>126</volume><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXjtFSltL4%3D</pub-id><pub-id pub-id-type="doi">10.1007/s12039-013-0552-1</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quiroga</surname><given-names>J</given-names></name><name><surname>Portillo</surname><given-names>S</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Galvez</surname><given-names>J</given-names></name><name><surname>Abonia</surname><given-names>R</given-names></name><name><surname>Insuasty</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">An efficient synthesis of pyrazolo[3,4-<italic>b</italic>]pyridine-4-spiroindolinones by a three-component reaction of 5-aminopyrazoles, isatin, and cyclic β-diketones</article-title><source>Tetrahedron Lett.</source><year>2011</year><volume>52</volume><issue>21</issue><fpage>2664</fpage><lpage>2666</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXltFKju7w%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.tetlet.2011.03.067</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Efficient one-pot synthesis of novel spirooxindole derivatives via three-component reaction in aqueous medium</article-title><source>J. Comb. Chem.</source><year>2010</year><volume>12</volume><issue>4</issue><fpage>571</fpage><lpage>576</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2010mip..book.....C</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3cXmslelsLs%3D</pub-id><pub-id pub-id-type="doi">10.1021/cc100056p</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabiri</surname><given-names>M</given-names></name><name><surname>Tisseh</surname><given-names>ZN</given-names></name><name><surname>Nobahar</surname><given-names>M</given-names></name><name><surname>Bazgir</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Organic reaction in water: A highly efficient and environmentally friendly synthesis of spiro compounds catalyzed by L-proline</article-title><source>Helv. Chim. Acta</source><year>2011</year><volume>94</volume><fpage>824</fpage><lpage>830</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3MXlvFGgtb4%3D</pub-id><pub-id pub-id-type="doi">10.1002/hlca.201000307</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>S</given-names></name><name><surname>Sindhu</surname><given-names>J</given-names></name><name><surname>Khurana</surname><given-names>JM</given-names></name></person-group><article-title xml:lang="en">Efficient green approach for the synthesis of spiro[indoline-3,4′-pyrazolo[3,4-b]quinoline]diones using [NMP]H<sub>2</sub>PO<sub>4</sub> and solvatochromic and pH studies</article-title><source>Synth. Commun.</source><year>2015</year><volume>45</volume><issue>9</issue><fpage>1101</fpage><lpage>1113</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXktFKgsLo%3D</pub-id><pub-id pub-id-type="doi">10.1080/00397911.2014</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>WH</given-names></name><name><surname>Chen</surname><given-names>MN</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>XL</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name></person-group><article-title xml:lang="en">Choline chloride and lactic acid: A natural deep eutectic solvent for one-pot rapid construction of spiro[indoline-3,4′-pyrazolo[3,4-<italic>b</italic>]pyridines]</article-title><source>J. Mol. Liq.</source><year>2019</year><volume>278</volume><fpage>124</fpage><lpage>129</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1MXhslCiu7Y%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.molliq.2019.01.065</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>YR</given-names></name><name><surname>Hu</surname><given-names>YJ</given-names></name><name><surname>Zhou</surname><given-names>XH</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>XF</given-names></name></person-group><article-title xml:lang="en">One-pot construction of spirooxindole backbone via biocatalytic domino reaction</article-title><source>Tetrahedron Lett.</source><year>2017</year><volume>58</volume><fpage>2923</fpage><lpage>2926</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXhtVyrs7rM</pub-id><pub-id pub-id-type="doi">10.1016/j.tetlet.2017.06.031</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kui</surname><given-names>D</given-names></name><name><surname>Lemao</surname><given-names>Y</given-names></name><name><surname>Yingjie</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Meiyang</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Efficient multicomponent synthesis of spirooxindole derivatives catalyzed by copper triflate</article-title><source>Polycycl. Aromat. Compd.</source><year>2022</year><volume>42</volume><fpage>277</fpage><lpage>289</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXjsVals7g%3D</pub-id><pub-id pub-id-type="doi">10.1080/10406638.2020.1726976</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>TJ</given-names></name></person-group><article-title xml:lang="en">Sonochemistry and the environment—Providing a ‘green’ link between chemistry, physics and engineering</article-title><source>Ultrason. Sonochem.</source><year>2007</year><volume>14</volume><fpage>476</fpage><lpage>483</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2sXisVKluro%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ultsonch.2006.10.008</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelit</surname><given-names>E</given-names></name><name><surname>Turgut</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Three-component aza-Diels-Alder reactions using Yb(OTf)<sub>3</sub> catalyst under conventional/ultrasonic techniques</article-title><source>Ultrason. Sonochem.</source><year>2014</year><volume>21</volume><fpage>1600</fpage><lpage>1607</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXhs1Cltrs%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ultsonch.2014.01.009</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelit</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">CSA catalyzed multi-component synthesis of polycyclic pyrazolo[4,3-<italic>e</italic>]pyridines under ultrasonic irradiation and their antioxidant activity</article-title><source>J. Turk. Chem. Soc. Sect. A</source><year>2017</year><volume>4</volume><fpage>631</fpage><lpage>648</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXkt1ers70%3D</pub-id><pub-id pub-id-type="doi">10.18596/jotcsa.295465</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelit</surname><given-names>E</given-names></name><name><surname>Turgut</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">Synthesis of enantiopure aminonaphthol derivatives under conventional/ultrasonic technique and their ring-closure reaction</article-title><source>Arab. J. Chem.</source><year>2016</year><volume>9</volume><fpage>421</fpage><lpage>429</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2cXksF2gsr4%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.arabjc.2014.02.017</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelit</surname><given-names>E</given-names></name><name><surname>Turgut</surname><given-names>Z</given-names></name></person-group><article-title xml:lang="en">(+)-CSA catalyzed multicomponent synthesis of 1-[(1, 3-Thiazol-2-ylamino) methyl]-2-naphthols and their ring-closure reaction under ultrasonic irradiation</article-title><source>J. Chem.</source><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/9315614</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Samanta</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">(±)-CSA catalyzed Friedel-Crafts alkylation of indoles with 3-ethoxycarbonyl-3- hydoxyisoindolin-1-one: An easy access of 3-ethoxycarbonyl-3-indolylisoindolin-1-ones bearing a quaternary α-amino acid moiety</article-title><source>Tetrahedron Lett.</source><year>2013</year><volume>54</volume><fpage>1444</fpage><lpage>2144</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC3sXhslWksbg%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.tetlet.2013.01.010</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">(D, L)- 10-camphorsulfonic-acid-catalysed synthesis of diaryl-fused 2,8-dioxabicyclo[3.3.1]nonanes from 2-hydroxychalcones and naphthol derivatives</article-title><source>Eur. J. Organ. Chem.</source><year>2014</year><pub-id pub-id-type="doi">10.1002/ejoc.201301295</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Srivastava, A., Mobin, S.M. &amp; Samata, S. (±)CSA catalyzed one-pot synthesis of 6,7-dihydrospiro[indole-3,1-isoindoline]-
2,3,4[1H,5H)-trione derivatives: Easy access of spirooxindoles and ibophyllidien-like alkaloids. <italic>Tetrahedron Lett.</italic><bold>55</bold>, 1863–1867. <ext-link xlink:href="10.1016/j.tetlet.2014.01.154" ext-link-type="doi">https://doi.org/10.1016/j.tetlet.2014.01.154</ext-link> (2014).</mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Ou</surname><given-names>B</given-names></name><name><surname>Prior</surname><given-names>RL</given-names></name></person-group><article-title xml:lang="en">The chemistry behind antioxidant capacity assays</article-title><source>J. Agric. Food Chem.</source><year>2005</year><volume>53</volume><issue>6</issue><fpage>1841</fpage><lpage>1856</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD2MXhslaltLo%3D</pub-id><pub-id pub-id-type="doi">10.1021/jf030723c</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Hua</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Pu</surname><given-names>L</given-names></name><name><surname>Xiang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Bacterial and fungal co-infections among COVID-19 patients in intensive care unit</article-title><source>Microbes Infect.</source><year>2021</year><volume>23</volume><issue>4–5</issue><fpage>104806</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhtlyqu73M</pub-id><pub-id pub-id-type="doi">10.1016/j.micinf.2021.104806</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>You</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Guddat</surname><given-names>LW</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors</article-title><source>Nature</source><year>2020</year><volume>582</volume><issue>7811</issue><fpage>289</fpage><lpage>293</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2020Natur.582..289J</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtVyhsrrO</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2223-y</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares da Costa</surname><given-names>TP</given-names></name><name><surname>Tieu</surname><given-names>W</given-names></name><name><surname>Yap</surname><given-names>MY</given-names></name><name><surname>Pendini</surname><given-names>NR</given-names></name><name><surname>Polyak</surname><given-names>SW</given-names></name><name><surname>Sejer Pedersen</surname><given-names>D</given-names></name><name><surname>Morona</surname><given-names>R</given-names></name><name><surname>Turnidge</surname><given-names>JD</given-names></name><name><surname>Wallace</surname><given-names>JC</given-names></name><name><surname>Wilce</surname><given-names>MCJ</given-names></name><name><surname>Booker</surname><given-names>GW</given-names></name><name><surname>Abell</surname><given-names>AD</given-names></name></person-group><article-title xml:lang="en">Selective inhibition of biotin protein ligase from <italic>Staphylococcus aureus</italic></article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><issue>21</issue><fpage>17823</fpage><lpage>17832</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC38XntFSmsLw%3D</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M112.356576</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarshi</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>EH</given-names></name><name><surname>Sung</surname><given-names>MW</given-names></name><name><surname>Nam</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>Kim</surname><given-names>EE</given-names></name><name><surname>Hwang</surname><given-names>KY</given-names></name></person-group><article-title xml:lang="en">Structural insights into the alanine racemase from <italic>Enterococcus faecalis</italic></article-title><source>Biochim. Biophys. (BBA)—Proteins Proteom.</source><year>2009</year><volume>1794</volume><issue>7</issue><fpage>1030</fpage><lpage>1040</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXmtVKkt74%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bbapap.2009.03.006</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamer</surname><given-names>O</given-names></name><name><surname>Avcı</surname><given-names>D</given-names></name><name><surname>Çelikoğlu</surname><given-names>E</given-names></name><name><surname>Idil</surname><given-names>O</given-names></name><name><surname>Atalay</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Crystal growth, structural and spectroscopic characterization, antimicrobial activity, DNA cleavage, molecular docking and density functional theory calculations of Zn(II) complex with 2-pyridinecarboxylic acid</article-title><source>Appl. Organomet. Chem.</source><year>2018</year><volume>32</volume><fpage>e4540</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXhs1emsLzK</pub-id><pub-id pub-id-type="doi">10.1002/aoc.4540</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamer</surname><given-names>Ö</given-names></name><name><surname>Avcı</surname><given-names>D</given-names></name><name><surname>Çelikoğlu</surname><given-names>E</given-names></name><name><surname>İdil</surname><given-names>Ö</given-names></name><name><surname>Atalay</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Crystal growth, structural and spectroscopic characterization, antimicrobial activity, DNA cleavage, molecular docking and density functional theory calculations of Zn (II) complex with 2-pyridinecarboxylic acid</article-title><source>Appl. Organomet. Chem.</source><year>2018</year><volume>32</volume><issue>11</issue><fpage>e4540</fpage><pub-id pub-id-type="doi">10.1002/aoc.4540</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buyukkidan</surname><given-names>N</given-names></name><name><surname>Yenikaya</surname><given-names>C</given-names></name><name><surname>Ilkimen</surname><given-names>H</given-names></name><name><surname>Karahan</surname><given-names>C</given-names></name><name><surname>Darcan</surname><given-names>C</given-names></name><name><surname>Korkmaz</surname><given-names>T</given-names></name><name><surname>Suzen</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Synthesis, characterization and biological activities of metal (II) dipicolinate complexes derived from pyridine-2, 6-dicarboxylic acid and 2-(piperazin-1-yl) ethanol</article-title><source>J. Mol. Struct.</source><year>2015</year><volume>1101</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2015JMoSt1101..139B</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2MXhsVCntrvJ</pub-id><pub-id pub-id-type="doi">10.1016/j.molstruc.2015.08.015</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asiri</surname><given-names>YI</given-names></name><name><surname>Muhsinah</surname><given-names>AB</given-names></name><name><surname>Alsayari</surname><given-names>A</given-names></name><name><surname>Venkatesan</surname><given-names>K</given-names></name><name><surname>Al-Ghorbani</surname><given-names>M</given-names></name><name><surname>Mabkhot</surname><given-names>MN</given-names></name></person-group><article-title xml:lang="en">Design, synthesis and antimicrobial activity of novel 2-aminothiophene containing cyclic and heterocyclic moieties</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2021</year><volume>44</volume><fpage>128117</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhtFGlsrnO</pub-id><pub-id pub-id-type="doi">10.1016/j.bmcl.2021.128117</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinde</surname><given-names>RA</given-names></name><name><surname>Adole</surname><given-names>VA</given-names></name><name><surname>Jagdale</surname><given-names>BS</given-names></name><name><surname>Pawar</surname><given-names>TB</given-names></name></person-group><article-title xml:lang="en">Superfast synthesis, antibacterial and antifungal studies of halo-aryl and heterocyclic tagged 2,3-dihydro-1H-inden-1-one candidates</article-title><source>Monatsh. für Chem.—Chem. Mon.</source><year>2021</year><volume>152</volume><fpage>649</fpage><lpage>658</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXhtV2ks7%2FP</pub-id><pub-id pub-id-type="doi">10.1007/s00706-021-02772-0</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Donnell</surname><given-names>F</given-names></name><name><surname>Smyth</surname><given-names>TJP</given-names></name><name><surname>Ramachandran</surname><given-names>VN</given-names></name><name><surname>Smyth</surname><given-names>WF</given-names></name></person-group><article-title xml:lang="en">A study of the antimicrobial activity of selected synthetic and naturally occurring quinolines</article-title><source>Int. J. Antimicrob. Agents</source><year>2010</year><volume>35</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXhsFanurrM</pub-id><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2009.06.031</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>SY</given-names></name><name><surname>Davis</surname><given-names>JS</given-names></name><name><surname>Eichenberger</surname><given-names>E</given-names></name><name><surname>Holland</surname><given-names>TL</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names></name></person-group><article-title xml:lang="en"><italic>Staphylococcus aureus</italic> infections: Epidemiology, pathophysiology, clinical manifestations, and management</article-title><source>Clin. Microbiol. Rev.</source><year>2015</year><volume>28</volume><issue>3</issue><fpage>603</fpage><lpage>661</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC1cXltlyhsrw%3D</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00134-14</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanlı</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Hastane kokenli ve toplum kaynaklı <italic>Staphylococcus</italic><italic>aureus</italic> suslarının cesitli antimikrobiyallere duyarlılıkları</article-title><source>IKSSTD</source><year>2020</year><volume>12</volume><issue>2</issue><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.5222/iksstd.2020.64326</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adeiza</surname><given-names>SS</given-names></name><name><surname>Shuaibu</surname><given-names>AB</given-names></name><name><surname>Shuaibu</surname><given-names>GM</given-names></name></person-group><article-title xml:lang="en">Random effects meta-analysis of COVID-19/<italic>S</italic>. <italic>aureus</italic> partnership in co-infection</article-title><source>GMS Hyg. Infect. Control.</source><year>2020</year><volume>15</volume><fpage>Doc29</fpage><pub-id pub-id-type="doi">10.3205/dgkh000364</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Rahman</surname><given-names>LH</given-names></name><name><surname>Abu-Dief</surname><given-names>AM</given-names></name><name><surname>Basha</surname><given-names>M</given-names></name><name><surname>Abdel-Mawgoud</surname><given-names>AAH</given-names></name></person-group><article-title xml:lang="en">Three novel Ni(II), VO(II) and Cr(III) mononuclear complexes encompassing potentially tridentate imine ligand: Synthesis, structural characterization, DNA interaction, antimicrobial evaluation and anticancer activity</article-title><source>Appl. Organomet. Chem.</source><year>2017</year><volume>31</volume><fpage>e3750</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BC2sXislGrtLg%3D</pub-id><pub-id pub-id-type="doi">10.1002/aoc.3750</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Dief</surname><given-names>AM</given-names></name><name><surname>El-Metwaly</surname><given-names>NM</given-names></name><name><surname>Alzahrani</surname><given-names>SO</given-names></name><name><surname>Bawazeer</surname><given-names>AM</given-names></name><name><surname>Shaaban</surname><given-names>S</given-names></name><name><surname>Adam</surname><given-names>MSS</given-names></name></person-group><article-title xml:lang="en">Targeting ctDNA binding and elaborated in-vitro assessments concerning novel Schiff base complexes: Synthesis, characterization, DFT and detailed in-silico confirmation</article-title><source>J. Mol. Liq.</source><year>2021</year><volume>322</volume><fpage>114977</fpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3MXktFaksA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.molliq.2020.114977</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="other">Hatha, A. A. M., Chandran, A., Asit, M., Sherin, V., Thomas, A. P. Influence of a salt water regulator on the survival response of <italic>Salmonella</italic> Paratyphi in Vembanadu Lake: India (2013).</mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand-Williams</surname><given-names>W</given-names></name><name><surname>Cuvelier</surname><given-names>ME</given-names></name><name><surname>Berset</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Use of a free radical method to evaluate antioxidant activity</article-title><source>LWT—Food Sci. Technol.</source><year>1995</year><volume>28</volume><fpage>25</fpage><lpage>30</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK2MXjvV2itLw%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0023-6438(95)80008-5</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Costa</surname><given-names>TPS</given-names></name><name><surname>Tieu</surname><given-names>W</given-names></name><name><surname>Yap</surname><given-names>MY</given-names></name><name><surname>Pendini</surname><given-names>NR</given-names></name><name><surname>Polyak</surname><given-names>SW</given-names></name><name><surname>Pedersen</surname><given-names>DS</given-names></name><name><surname>Abell</surname><given-names>AD</given-names></name></person-group><article-title xml:lang="en">Selective inhibition of biotin protein ligase from <italic>Staphylococcus aureus</italic></article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><issue>21</issue><fpage>17823</fpage><lpage>17832</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.356576</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarshi</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>EH</given-names></name><name><surname>Sung</surname><given-names>MW</given-names></name><name><surname>Nam</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>WH</given-names></name><name><surname>Kim</surname><given-names>EE</given-names></name><name><surname>Hwang</surname><given-names>KY</given-names></name></person-group><article-title xml:lang="en">Structural insights into the alanine racemase from <italic>Enterococcus faecalis</italic></article-title><source>Biochim. Biophys. Acta (BBA)—Proteins Proteom.</source><year>2009</year><volume>1794</volume><issue>7</issue><fpage>1030</fpage><lpage>1040</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXmtVKkt74%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bbapap.2009.03.006</pub-id></mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors</article-title><source>Nature</source><year>2020</year><volume>582</volume><issue>7811</issue><fpage>289</fpage><lpage>293</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2020Natur.582..289J</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BB3cXhtVyhsrrO</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2223-y</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>HM</given-names></name><etal/></person-group><article-title xml:lang="en">The protein data bank</article-title><source>Nucleic Acids Res.</source><year>2000</year><volume>28</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">2000spam.book.....B</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD3cXhvVKjt7w%3D</pub-id><pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="other"><ext-link xlink:href="https://3ds.com/products-services/biovia/products" ext-link-type="uri">https://3ds.com/products-services/biovia/products</ext-link>.</mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becke</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Density-functional thermochemistry. III. The role of exact exchange</article-title><source>J. Chem. Phys.</source><year>1993</year><volume>98</volume><fpage>5648</fpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">1993JChPh..98.5648B</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaK3sXisVWgtrw%3D</pub-id><pub-id pub-id-type="doi">10.1063/1.464913</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Parr</surname><given-names>RG</given-names></name></person-group><article-title xml:lang="en">Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density</article-title><source>Phys. Rev. B</source><year>1988</year><volume>37</volume><issue>2</issue><fpage>785</fpage><pub-id pub-id-type="other" assigning-authority="NASA Astrophysics Data System">1988PhRvB..37..785L</pub-id><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DyaL1cXktFWrtbw%3D</pub-id><pub-id pub-id-type="doi">10.1103/PhysRevB.37.785</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trott</surname><given-names>O</given-names></name><name><surname>Olson</surname><given-names>AJ</given-names></name></person-group><article-title xml:lang="en">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title><source>J. Comput. Chem.</source><year>2010</year><volume>31</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="other" assigning-authority="ChemPort ( Chemical Abstract Service )">1:CAS:528:DC%2BD1MXhsFGnur3O</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1" specific-use="web-only"><sec id="Sec32"><title>Supplementary Information</title><p id="Par61"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary Information"><media mimetype="application" mime-subtype="pdf" xlink:href="MediaObjects/41598_2023_27777_MOESM1_ESM.pdf" position="anchor"><caption xml:lang="en"><p>Supplementary Figures.</p></caption></media></supplementary-material></p></sec></app></app-group><notes notes-type="ESMHint"><title>Supplementary Information</title><p>The online version contains supplementary material available at <ext-link xlink:href="10.1038/s41598-023-27777-z" ext-link-type="doi">https://doi.org/10.1038/s41598-023-27777-z</ext-link>.</p></notes><notes notes-type="Misc"><title>Publisher's note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Science, Humanities and Social Sciences, multidisciplinary</facet-value><facet-value count="1">Science, multidisciplinary</facet-value></facet><facet name="keyword"/><facet name="pub"><facet-value count="1">Scientific Reports</facet-value></facet><facet name="year"><facet-value count="1">2023</facet-value></facet><facet name="country"><facet-value count="1">Turkey</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
